{
  "conditions_to_closing": [
    {
      "section": "conditions_to_closing",
      "field_name": "mutual_conditions_list",
      "answer": [
        "The Required Company Stockholder Vote shall have been obtained.",
        "No injunction or similar order by any Governmental Authority that prohibits the consummation of the Merger or the Carve-Out shall have been entered and shall continue to be in effect.",
        "No Law shall have been enacted, entered, promulgated, enforced, or deemed applicable by any Governmental Authority that prohibits or makes illegal the Merger or the Carve-Out.",
        "Any waiting period under the HSR Act and the filings specified in Section 7.01(c) of the Company Disclosure Schedule applicable to the Merger or the Carve-Out shall have expired or been earlier terminated.",
        "All other actions or nonactions, waivers, consents, clearances, decisions, declarations, approvals, and all expirations of waiting periods with respect to the Merger or the Carve-Out specified in Section 7.01(c) of the Company Disclosure Schedule shall have been made, expired, terminated, or obtained.",
        "All Requisite Regulatory Approvals shall be in full force and effect."
      ],
      "summary": "The mutual conditions for closing include obtaining stockholder approval, absence of legal restraints, expiration of waiting periods under the HSR Act, and obtaining all requisite regulatory approvals.",
      "confidence": 0.95,
      "reason": "The conditions listed in Section 7.01 are explicitly stated as mutual conditions to closing the merger.",
      "clause_text": "The obligations of the Parties to consummate the Merger are subject to the satisfaction, at or prior to the Closing, of each of the following conditions, to the extent applicable: (a) Stockholder Approval. The Required Company Stockholder Vote shall have been obtained. (b) No Legal Restraints. No (i) injunction or similar order by any Governmental Authority having jurisdiction over Parent, Merger Sub, the Company, the Investor, the Carve-Out Purchaser or any of their respective Affiliates that prohibits the consummation of the Merger or the Carve-Out shall have been entered and shall continue to be in effect or (ii) Law shall have been enacted, entered, promulgated, enforced, or deemed applicable by any Governmental Authority having jurisdiction over Parent, Merger Sub, the Company, the Investor, the Carve-Out Purchaser or any of their respective Affiliates that, in any case, prohibits or makes illegal the Merger or the Carve-Out (any such order, injunction, or Law in the foregoing clause (i) or (ii), a 'Legal Restraint'). (c) Regulatory Approvals. (i) Any waiting period under the HSR Act and the filings specified in Section 7.01(c) of the Company Disclosure Schedule applicable to the Merger or the Carve-Out (and any extension thereof) shall have expired or been earlier terminated, (ii) all other actions or nonactions, waivers, consents, clearances, decisions, declarations, approvals, and all expirations of waiting periods with respect to the Merger or the Carve-Out specified in Section 7.01(c) of the Company Disclosure Schedule shall have been made, expired, terminated, or obtained, as the case may be (all actions or nonactions, waivers, consents, clearances, decisions, declarations, approvals, and the lapse of waiting periods, including under the HSR Act, of such jurisdictions, being the 'Requisite Regulatory Approvals'), and (iii) all Requisite Regulatory Approvals shall be in full force and effect.",
      "reference_section": "ARTICLE Article VII CONDITIONS PRECEDENT TO THE MERGER > Section 7.01 Conditions to Obligation of Each Party to Consummate the Merger"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "parent_closing_conditions",
      "answer": [
        "The representations and warranties of the Company set forth in Section 3.03 and Section 3.08(a) must be true and correct as of the Closing Date, except for de minimis inaccuracies.",
        "The representations and warranties in Sections 3.01, 3.02, 3.04, 3.05(a)(i), 3.06, 3.23, 3.24, and 3.27 must be true and correct in all material respects as of the Closing Date.",
        "Other representations and warranties of the Company in Article III must be true and correct, except where inaccuracies would not reasonably be likely to have a Material Adverse Effect.",
        "The Company must have performed all obligations required under the Agreement in all material respects at or prior to the Effective Time.",
        "The Company must deliver a certificate, dated as of the Closing Date, certifying that certain conditions have been satisfied.",
        "No events or circumstances resulting in a Material Adverse Effect must have occurred since the date of the Agreement.",
        "The condition in Section 7.01(b) must be satisfied without a Burdensome Condition.",
        "The condition in Section 7.01(c) must be satisfied without a Burdensome Condition."
      ],
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "company_closing_conditions",
      "answer": [
        "The representations and warranties of the Company set forth in Section 3.03 and Section 3.08(a) shall be true and correct as of the Closing Date.",
        "The representations and warranties in Section 3.01, Section 3.02, Section 3.04, Section 3.05(a)(i), Section 3.06, Section 3.23, Section 3.24, and Section 3.27 shall be true and correct in all material respects as of the Closing Date.",
        "The other representations and warranties of the Company set forth in Article III shall be true and correct as of the Closing Date, except where the failure would not reasonably be likely to have a Material Adverse Effect.",
        "The Company shall have performed in all material respects all obligations required to be performed by it under this Agreement at or prior to the Effective Time.",
        "The Company shall have delivered to Parent a certificate, dated as of the Closing Date, certifying that the conditions set forth in Section 7.03(a), Section 7.03(b), and Section 7.03(d) have been satisfied.",
        "Since the date of this Agreement, there shall have occurred no events or circumstances that have resulted in a Material Adverse Effect.",
        "The condition set forth in Section 7.01(b) shall have been satisfied without the imposition of a Burdensome Condition.",
        "The condition set forth in Section 7.01(c) shall have been satisfied without the imposition of a Burdensome Condition."
      ],
      "summary": "The Company must ensure the accuracy of its representations and warranties, perform all obligations, deliver a certificate of compliance, and ensure no Material Adverse Effect has occurred.",
      "confidence": 0.95,
      "reason": "The conditions to the obligations of the Company to close the transaction are explicitly outlined in Section 7.03.",
      "clause_text": "The obligations of Parent and Merger Sub to consummate the Merger are further subject to the satisfaction (or waiver by Parent, on its own behalf and on behalf of Merger Sub, to the extent permitted by applicable Law) of the following conditions: (a) (i) The representations and warranties of the Company set forth in Section 3.03 (except for de minimis inaccuracies) and Section 3.08(a) shall be true and correct, as of the Closing Date, as if made on and as of the Closing Date (except to the extent expressly made as of an earlier date, in which case as of such date); (ii) Section 3.01, Section 3.02, Section 3.04, Section 3.05(a)(i), Section 3.06, Section 3.23, Section 3.24 and Section 3.27 shall be true and correct in all material respects as of the Closing Date, as if made on and as of the Closing Date (except to the extent expressly made as of an earlier date, in which case as of such date); and (iii) the other representations and warranties of the Company set forth in Article III (disregarding all materiality and Material Adverse Effect qualifications contained therein) shall be true and correct as of the Closing Date, as if made on and as of the Closing Date (except to the extent expressly made as of an earlier date, in which case as of such date), except with respect to this clause (iii), where the failure of such representations and warranties to be so true and correct would not, individually or in the aggregate, reasonably be likely to have a Material Adverse Effect. (b) The Company shall have performed in all material respects all obligations required to be performed by it under this Agreement at or prior to the Effective Time. (c) The Company shall have delivered to Parent a certificate, dated as of the Closing Date, and signed by its Chief Executive Officer or another senior officer, certifying to the effect that the conditions set forth in Section 7.03(a), Section 7.03(b) and Section 7.03(d) have been satisfied. (d) Since the date of this Agreement, there shall have occurred no events or circumstances that individually or in the aggregate have resulted in a Material Adverse Effect. (e) The condition set forth in Section 7.01(b) (if the Legal Restraint relates to any of the matters referenced in Section 7.01(c)) shall have been satisfied without the imposition of a Burdensome Condition (including any Burdensome Condition that would come into effect at the Closing). (f) The condition set forth in Section 7.01(c) shall have been satisfied without the imposition of a Burdensome Condition (including any Burdensome Condition that would come into effect at the Closing).",
      "reference_section": "ARTICLE Article VII CONDITIONS PRECEDENT TO THE MERGER > Section 7.03 Conditions to Obligations of Parent and Merger Sub to Consummate the Merger"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "target_shareholder_approval_required",
      "answer": true,
      "summary": "The agreement explicitly requires the affirmative vote of the holders of a majority of the shares of Company Common Stock as a condition to closing the merger.",
      "confidence": 1.0,
      "reason": "The clause explicitly states that the Required Company Stockholder Vote must be obtained.",
      "clause_text": "The affirmative vote of the holders of a majority of the shares of Company Common Stock outstanding on the record date for the Company Stockholders' Meeting in favor of adopting this Agreement (the 'Required Company Stockholder Vote') is the only vote of the holders of any class or series of the Company's capital stock, or any holder of any other security of the Company, necessary to adopt this Agreement and approve the Merger.",
      "reference_section": "ARTICLE Article III REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 3.06 Vote Required"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "target_shareholder_approval_threshold",
      "answer": "majority of the shares of Company Common Stock outstanding",
      "summary": "The affirmative vote of the holders of a majority of the shares of Company Common Stock outstanding is required for Target shareholder approval to close the transaction.",
      "confidence": 1.0,
      "reason": "The document explicitly states the required threshold for shareholder approval.",
      "clause_text": "The affirmative vote of the holders of a majority of the shares of Company Common Stock outstanding on the record date for the Company Stockholders' Meeting in favor of adopting this Agreement (the 'Required Company Stockholder Vote') is the only vote of the holders of any class or series of the Company's capital stock, or any holder of any other security of the Company, necessary to adopt this Agreement and approve the Merger.",
      "reference_section": "ARTICLE Article III REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 3.06 Vote Required"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "hsr_clearance_required",
      "answer": true,
      "summary": "The agreement explicitly requires HSR Act clearance as a condition to closing the transaction.",
      "confidence": 1.0,
      "reason": "The document specifies that any waiting period under the HSR Act must have expired or been terminated as a condition to closing.",
      "clause_text": "Any waiting period under the HSR Act and the filings specified in Section 7.01(c) of the Company Disclosure Schedule applicable to the Merger or the Carve-Out (and any extension thereof) shall have expired or been earlier terminated.",
      "reference_section": "ARTICLE Article VII CONDITIONS PRECEDENT TO THE MERGER > Section 7.01 Conditions to Obligation of Each Party to Consummate the Merger"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "other_customary_conditions",
      "answer": [
        "Stockholder Approval",
        "No Legal Restraints",
        "Regulatory Approvals"
      ],
      "summary": "The obligations to consummate the Merger are subject to conditions including stockholder approval, absence of legal restraints, and obtaining requisite regulatory approvals.",
      "confidence": 0.95,
      "reason": "The conditions listed are standard requirements for closing a merger, as they include stockholder approval, absence of legal restraints, and necessary regulatory approvals.",
      "clause_text": "The respective obligations of each Party to consummate the Merger shall be subject to the satisfaction (or waiver by Parent, on its own behalf and on behalf of Merger Sub, and the Company to the extent permitted by applicable Law) at or prior to the Effective Time of the following conditions: (a) Stockholder Approval. The Required Company Stockholder Vote shall have been obtained. (b) No Legal Restraints. No (i) injunction or similar order by any Governmental Authority having jurisdiction over Parent, Merger Sub, the Company, the Investor, the Carve-Out Purchaser or any of their respective Affiliates that prohibits the consummation of the Merger or the Carve-Out shall have been entered and shall continue to be in effect or (ii) Law shall have been enacted, entered, promulgated, enforced, or deemed applicable by any Governmental Authority having jurisdiction over Parent, Merger Sub, the Company, the Investor, the Carve-Out Purchaser or any of their respective Affiliates that, in any case, prohibits or makes illegal the Merger or the Carve-Out (any such order, injunction, or Law in the foregoing clause (i) or (ii), a \"Legal Restraint\"). (c) Regulatory Approvals. (i) Any waiting period under the HSR Act and the filings specified in Section 7.01(c) of the Company Disclosure Schedule applicable to the Merger or the Carve-Out (and any extension thereof) shall have expired or been earlier terminated, (ii) all other actions or nonactions, waivers, consents, clearances, decisions, declarations, approvals, and all expirations of waiting periods with respect to the Merger or the Carve-Out specified in Section 7.01(c) of the Company Disclosure Schedule shall have been made, expired, terminated, or obtained, as the case may be (all actions or nonactions, waivers, consents, clearances, decisions, declarations, approvals, and the lapse of waiting periods, including under the HSR Act, of such jurisdictions, being the \"Requisite Regulatory Approvals\"), and (iii) all Requisite Regulatory Approvals shall be in full force and effect.",
      "reference_section": "ARTICLE Article VII CONDITIONS PRECEDENT TO THE MERGER > Section 7.01 Conditions to Obligation of Each Party to Consummate the Merger"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "financial_conditions_minimum_cash_threshold",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "financial_conditions_maximum_net_debt",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "financial_conditions_minimum_any_condition",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "tax_conditions_tax_opinion_required",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    }
  ],
  "material_adverse_effect": {
    "mae_carveout": [
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_general_economic_conditions_included",
        "answer": true,
        "summary": "The MAE definition excludes adverse effects resulting from actions taken by the Company at the written direction of Parent or actions specifically required by the terms of the Agreement.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that actions taken at the written direction of Parent or required by the Agreement are excluded from being considered a Material Adverse Effect.",
        "clause_text": "(viii) any action taken (or failure to act) by the Company or any Company Subsidiary at the written direction of Parent or any action specifically required to be taken by the Company or any Company Subsidiary by the terms of this Agreement;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_general_economic_conditions_explanation",
        "answer": "Adverse effects resulting from general economic conditions are excluded from the definition of Material Adverse Effect.",
        "summary": "The clause specifies that adverse effects from general economic conditions, such as changes in markets, interest rates, inflation, or geopolitical events, are excluded from being considered a Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that general economic conditions and related factors shall not be taken into account in determining a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect means any change, effect, event, occurrence or development that, individually or in the aggregate with all other changes, effects, events, occurrences or developments, has had or would reasonably be expected to have a material adverse effect on the business condition (financial or otherwise), assets, or results of operations of the Company and the Company Subsidiaries, taken as a whole; provided that, no change, effect, event, occurrence or development, arising out of or resulting from any of the following shall be deemed either alone or in combination to constitute a Material Adverse Effect, and none of the following shall be taken into account in determining whether there is, or would reasonably likely to be, a Material Adverse Effect: ... (iv) general economic conditions (or changes therein) or other general business, financial, credit, securities or other capital markets conditions (including interest rates, exchange rates, tariffs, trade wars, credit markets, inflation or inflation rates, or the prices or availability of commodities, raw materials, or energy supply used by the Company or any Company Subsidiary) in the global, U.S., or any other national or regional economy;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_industry_conditions_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes changes generally affecting the industries in which the Company operates from constituting a Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that changes generally affecting any of the industries in which the Company operates shall not be deemed to constitute a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect means any change, effect, event, occurrence or development that, individually or in the aggregate with all other changes, effects, events, occurrences or developments, has had or would reasonably be expected to have a material adverse effect on the business condition (financial or otherwise), assets, or results of operations of the Company and the Company Subsidiaries, taken as a whole; provided that, no change, effect, event, occurrence or development, arising out of or resulting from any of the following shall be deemed either alone or in combination to constitute a Material Adverse Effect, and none of the following shall be taken into account in determining whether there is, or would reasonably likely to be, a Material Adverse Effect: (iii) any change, effect, event, occurrence or development generally affecting any of the industries or geographies in which the Company or any Company Subsidiary operates, including competition in any of the geographic areas in which the Company or any Company Subsidiary operates;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_industry_conditions_explanation",
        "answer": "any change, effect, event, occurrence or development generally affecting any of the industries or geographies in which the Company or any Company Subsidiary operates, including competition in any of the geographic areas in which the Company or any Company Subsidiary operates",
        "summary": "The clause excludes changes generally affecting the industries or geographies in which the Company operates from the Material Adverse Effect definition.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that changes affecting the industries or geographies in which the Company operates are excluded from the Material Adverse Effect definition.",
        "clause_text": "any change, effect, event, occurrence or development generally affecting any of the industries or geographies in which the Company or any Company Subsidiary operates, including competition in any of the geographic areas in which the Company or any Company Subsidiary operates",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_stock_price_changes_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes changes in the market price or trading volume of the Company Common Stock from constituting a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that changes in the market price or trading volume of the Company Common Stock shall not be deemed to constitute a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect means any change, effect, event, occurrence or development that, individually or in the aggregate with all other changes, effects, events, occurrences or developments, has had or would reasonably be expected to have a material adverse effect on the business condition (financial or otherwise), assets, or results of operations of the Company and the Company Subsidiaries, taken as a whole; provided that, no change, effect, event, occurrence or development, arising out of or resulting from any of the following shall be deemed either alone or in combination to constitute a Material Adverse Effect, and none of the following shall be taken into account in determining whether there is, or would reasonably likely to be, a Material Adverse Effect: (i) any change in the market price or trading volume of the Company Common Stock or the credit rating of the Company or any Company Subsidiary and any changes in any analysts' recommendations or ratings with respect to the Company or any Company Subsidiary or any of their respective securities (it being understood that the underlying facts or occurrences giving rise to such change may be taken into account in determining whether there has been or will be a Material Adverse Effect, to the extent not otherwise excluded from this definition);",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_stock_price_changes_explanation",
        "answer": "any change in the market price or trading volume of the Company Common Stock or the credit rating of the Company or any Company Subsidiary and any changes in any analysts' recommendations or ratings with respect to the Company or any Company Subsidiary or any of their respective securities (it being understood that the underlying facts or occurrences giving rise to such change may be taken into account in determining whether there has been or will be a Material Adverse Effect, to the extent not otherwise excluded from this definition)",
        "summary": "Changes in the Company's stock price, market capitalization, or trading volume are excluded from the MAE definition, though underlying causes may still be considered.",
        "confidence": 0.95,
        "reason": "The clause explicitly excludes changes in stock price, market capitalization, or trading volume from being considered a Material Adverse Effect.",
        "clause_text": "any change in the market price or trading volume of the Company Common Stock or the credit rating of the Company or any Company Subsidiary and any changes in any analysts' recommendations or ratings with respect to the Company or any Company Subsidiary or any of their respective securities (it being understood that the underlying facts or occurrences giving rise to such change may be taken into account in determining whether there has been or will be a Material Adverse Effect, to the extent not otherwise excluded from this definition)",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_credit_rating_changes_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes changes in credit ratings, analyst outlooks, or recommendations from constituting a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that changes in the credit rating of the Company or any Company Subsidiary and any changes in any analysts' recommendations or ratings shall not be deemed to constitute a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect means any change, effect, event, occurrence or development... provided that, no change, effect, event, occurrence or development, arising out of or resulting from any of the following shall be deemed either alone or in combination to constitute a Material Adverse Effect... (i) any change in the market price or trading volume of the Company Common Stock or the credit rating of the Company or any Company Subsidiary and any changes in any analysts' recommendations or ratings with respect to the Company or any Company Subsidiary...",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_credit_rating_changes_explanation",
        "answer": "Changes in the credit rating of the Company or any Company Subsidiary and any changes in any analysts' recommendations or ratings with respect to the Company or any Company Subsidiary or any of their respective securities are excluded from the definition of Material Adverse Effect.",
        "summary": "The definition of Material Adverse Effect excludes changes in credit ratings and analysts' recommendations or ratings.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that changes in credit ratings and analysts' recommendations are not considered a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect means any change, effect, event, occurrence or development that, individually or in the aggregate with all other changes, effects, events, occurrences or developments, has had or would reasonably be expected to have a material adverse effect on the business condition (financial or otherwise), assets, or results of operations of the Company and the Company Subsidiaries, taken as a whole; provided that, no change, effect, event, occurrence or development, arising out of or resulting from any of the following shall be deemed either alone or in combination to constitute a Material Adverse Effect, and none of the following shall be taken into account in determining whether there is, or would reasonably likely to be, a Material Adverse Effect: (i) any change in the market price or trading volume of the Company Common Stock or the credit rating of the Company or any Company Subsidiary and any changes in any analysts' recommendations or ratings with respect to the Company or any Company Subsidiary or any of their respective securities (it being understood that the underlying facts or occurrences giving rise to such change may be taken into account in determining whether there has been or will be a Material Adverse Effect, to the extent not otherwise excluded from this definition);",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_legal_or_regulatory_changes_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes changes in laws, regulations, GAAP, or accounting principles from constituting a Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that changes in laws or GAAP shall not be deemed to constitute a Material Adverse Effect.",
        "clause_text": "any change in, or any compliance with or action taken for the purpose of complying with, any Law or GAAP (or interpretations of any Law or GAAP), including the adoption, implementation, promulgation, repeal, modification, reinterpretation, or proposal of any Law or new requirement under GAAP after the date hereof;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_legal_or_regulatory_changes_explanation",
        "answer": "any change in, or any compliance with or action taken for the purpose of complying with, any Law or GAAP (or interpretations of any Law or GAAP), including the adoption, implementation, promulgation, repeal, modification, reinterpretation, or proposal of any Law or new requirement under GAAP after the date hereof;",
        "summary": "Changes in laws, regulations, GAAP, or accounting principles are excluded from the Material Adverse Effect definition.",
        "confidence": 0.95,
        "reason": "The clause explicitly excludes changes in laws, regulations, GAAP, or accounting principles from being considered a Material Adverse Effect.",
        "clause_text": "any change in, or any compliance with or action taken for the purpose of complying with, any Law or GAAP (or interpretations of any Law or GAAP), including the adoption, implementation, promulgation, repeal, modification, reinterpretation, or proposal of any Law or new requirement under GAAP after the date hereof;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_force_majeure_events_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes acts of God, natural disasters, weather events, and other force majeure events from constituting a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that events such as acts of God, natural disasters, and weather-related events shall not be deemed to constitute a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect means any change, effect, event, occurrence or development that, individually or in the aggregate with all other changes, effects, events, occurrences or developments, has had or would reasonably be expected to have a material adverse effect on the business condition (financial or otherwise), assets, or results of operations of the Company and the Company Subsidiaries, taken as a whole; provided that, no change, effect, event, occurrence or development, arising out of or resulting from any of the following shall be deemed either alone or in combination to constitute a Material Adverse Effect, and none of the following shall be taken into account in determining whether there is, or would reasonably likely to be, a Material Adverse Effect: ... (v) ... any volcano, tsunami, earthquake, hurricane, tornado, other natural or man-made disaster, weather-related event, or act of God, or any other force majeure event ...",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_force_majeure_events_explanation",
        "answer": "The definition of Material Adverse Effect excludes acts of God, natural disasters, or weather-related events.",
        "summary": "The definition of Material Adverse Effect explicitly excludes acts of God, natural disasters, or weather-related events from being considered a Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly lists acts of God, natural disasters, and weather-related events as exclusions from the definition of Material Adverse Effect.",
        "clause_text": "Material Adverse Effect means any change, effect, event, occurrence or development that, individually or in the aggregate with all other changes, effects, events, occurrences or developments, has had or would reasonably be expected to have a material adverse effect on the business condition (financial or otherwise), assets, or results of operations of the Company and the Company Subsidiaries, taken as a whole; provided that, no change, effect, event, occurrence or development, arising out of or resulting from any of the following shall be deemed either alone or in combination to constitute a Material Adverse Effect, and none of the following shall be taken into account in determining whether there is, or would reasonably likely to be, a Material Adverse Effect: ... (v) ... any volcano, tsunami, earthquake, hurricane, tornado, other natural or man-made disaster, weather-related event, or act of God, or any other force majeure event ...",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_political_events_or_war_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes acts of war, terrorism, military conflict, or geopolitical instability from constituting a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that acts of terrorism, war, and similar events shall not be deemed to constitute a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect means any change, effect, event, occurrence or development that, individually or in the aggregate with all other changes, effects, events, occurrences or developments, has had or would reasonably be expected to have a material adverse effect on the business condition (financial or otherwise), assets, or results of operations of the Company and the Company Subsidiaries, taken as a whole; provided that, no change, effect, event, occurrence or development, arising out of or resulting from any of the following shall be deemed either alone or in combination to constitute a Material Adverse Effect, and none of the following shall be taken into account in determining whether there is, or would reasonably likely to be, a Material Adverse Effect: ... (v) any domestic, foreign or global political, regulatory, or social condition (including any actual or potential sequester, stoppage, shutdown, default, or similar event or occurrence by or involving any Governmental Authority affecting a national or federal government as a whole), any act of terrorism, war (whether or not declared, including the Russian-Ukrainian and Israeli-Palestinian conflicts, and escalations and effects thereof), civil unrest, civil disobedience, protests, public demonstrations, insurrection, national or international calamity, sabotage or terrorism (including cyberattacks, cyber intrusions, cyberterrorism or other cybersecurity breaches), pandemic or epidemic (including COVID-19 and reasonable compliance by the Company or any Company Subsidiary with any COVID-19 Measure), or other outbreaks of diseases or quarantine restrictions, or any other similar event, any volcano, tsunami, earthquake, hurricane, tornado, other natural or man-made disaster, weather-related event, or act of God, or any other force majeure event (and, in each case, including any escalation or worsening thereof and any action taken by any Governmental Authority in response to any of the foregoing (including requirements for business closures, restrictions on operations or “sheltering-in-place”));",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_political_events_or_war_explanation",
        "answer": "any domestic, foreign or global political, regulatory, or social condition (including any actual or potential sequester, stoppage, shutdown, default, or similar event or occurrence by or involving any Governmental Authority affecting a national or federal government as a whole), any act of terrorism, war (whether or not declared, including the Russian-Ukrainian and Israeli-Palestinian conflicts, and escalations and effects thereof), civil unrest, civil disobedience, protests, public demonstrations, insurrection, national or international calamity, sabotage or terrorism (including cyberattacks, cyber intrusions, cyberterrorism or other cybersecurity breaches), pandemic or epidemic (including COVID-19 and reasonable compliance by the Company or any Company Subsidiary with any COVID-19 Measure), or other outbreaks of diseases or quarantine restrictions, or any other similar event, any volcano, tsunami, earthquake, hurricane, tornado, other natural or man-made disaster, weather-related event, or act of God, or any other force majeure event (and, in each case, including any escalation or worsening thereof and any action taken by any Governmental Authority in response to any of the foregoing (including requirements for business closures, restrictions on operations or “sheltering-in-place”))",
        "summary": "The clause excludes acts of war, terrorism, armed conflict, or political instability from the Material Adverse Effect definition.",
        "confidence": 0.95,
        "reason": "The clause explicitly lists acts of war, terrorism, and political conditions as exclusions from the Material Adverse Effect definition.",
        "clause_text": "any domestic, foreign or global political, regulatory, or social condition (including any actual or potential sequester, stoppage, shutdown, default, or similar event or occurrence by or involving any Governmental Authority affecting a national or federal government as a whole), any act of terrorism, war (whether or not declared, including the Russian-Ukrainian and Israeli-Palestinian conflicts, and escalations and effects thereof), civil unrest, civil disobedience, protests, public demonstrations, insurrection, national or international calamity, sabotage or terrorism (including cyberattacks, cyber intrusions, cyberterrorism or other cybersecurity breaches), pandemic or epidemic (including COVID-19 and reasonable compliance by the Company or any Company Subsidiary with any COVID-19 Measure), or other outbreaks of diseases or quarantine restrictions, or any other similar event, any volcano, tsunami, earthquake, hurricane, tornado, other natural or man-made disaster, weather-related event, or act of God, or any other force majeure event (and, in each case, including any escalation or worsening thereof and any action taken by any Governmental Authority in response to any of the foregoing (including requirements for business closures, restrictions on operations or “sheltering-in-place”))",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_pandemic_health_events_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes pandemics, epidemics, or public health emergencies, including COVID-19, from constituting a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that pandemics, epidemics, including COVID-19, and compliance with COVID-19 Measures are excluded from being considered a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect means any change, effect, event, occurrence or development that, individually or in the aggregate with all other changes, effects, events, occurrences or developments, has had or would reasonably be expected to have a material adverse effect on the business condition (financial or otherwise), assets, or results of operations of the Company and the Company Subsidiaries, taken as a whole; provided that, no change, effect, event, occurrence or development, arising out of or resulting from any of the following shall be deemed either alone or in combination to constitute a Material Adverse Effect, and none of the following shall be taken into account in determining whether there is, or would reasonably likely to be, a Material Adverse Effect: ... (v) any domestic, foreign or global political, regulatory, or social condition ... pandemic or epidemic (including COVID-19 and reasonable compliance by the Company or any Company Subsidiary with any COVID-19 Measure), or other outbreaks of diseases or quarantine restrictions, or any other similar event ...",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_pandemic_health_events_explanation",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_agreement_compliance_effects_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes effects resulting from the negotiation, execution, announcement, pendency, or consummation of the Transactions from constituting a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that effects arising from the negotiation, execution, announcement, pendency, or consummation of the Transactions shall not be deemed to constitute a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect means any change, effect, event, occurrence or development that, individually or in the aggregate with all other changes, effects, events, occurrences or developments, has had or would reasonably be expected to have a material adverse effect on the business condition (financial or otherwise), assets, or results of operations of the Company and the Company Subsidiaries, taken as a whole; provided that, no change, effect, event, occurrence or development, arising out of or resulting from any of the following shall be deemed either alone or in combination to constitute a Material Adverse Effect, and none of the following shall be taken into account in determining whether there is, or would reasonably likely to be, a Material Adverse Effect: (ii) the negotiation, execution, announcement, pendency or consummation of the Transactions, the Carve-Out (including any action taken or omitted for the purpose of implementing the Carve-Out) or the terms of this Agreement...",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_agreement_compliance_effects_explanation",
        "answer": "The clause excludes effects resulting from the negotiation, execution, announcement, pendency, or consummation of the Transactions from being considered a Material Adverse Effect.",
        "summary": "The MAE definition excludes effects from the negotiation, execution, or announcement of the merger agreement.",
        "confidence": 0.95,
        "reason": "The clause explicitly lists these events as exclusions from the MAE definition.",
        "clause_text": "Material Adverse Effect means any change, effect, event, occurrence or development that, individually or in the aggregate with all other changes, effects, events, occurrences or developments, has had or would reasonably be expected to have a material adverse effect on the business condition (financial or otherwise), assets, or results of operations of the Company and the Company Subsidiaries, taken as a whole; provided that, no change, effect, event, occurrence or development, arising out of or resulting from any of the following shall be deemed either alone or in combination to constitute a Material Adverse Effect, and none of the following shall be taken into account in determining whether there is, or would reasonably likely to be, a Material Adverse Effect: (ii) the negotiation, execution, announcement, pendency or consummation of the Transactions, the Carve-Out (including any action taken or omitted for the purpose of implementing the Carve-Out) or the terms of this Agreement (including the identity of Parent or any of its Affiliates or any communication by Parent or any of its Affiliates regarding the plans or intentions of Parent or any of its Affiliates with respect to the composition or conduct of the business of the Company or any Company Subsidiary), including the impact of any of the foregoing on the relationships, contractual or otherwise, of the Company or any Company Subsidiary with employees, labor unions, works councils, financing sources, customers, franchisees, suppliers, partners, resellers, contract manufacturers, distributors, licensors, licensees, Governmental Authorities, or other business or regulatory relationships (other than for purposes of any representation or warranty in Section 3.05, but subject to disclosures in Section 3.05 of the Company Disclosure Schedule, to the extent the purpose of such representation or warranty is to address the consequences resulting from the execution of this Agreement or the consummation of the Transactions and the other transactions contemplated hereby);",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_parent_actions_included",
        "answer": true,
        "summary": "The MAE definition excludes adverse effects caused by actions or omissions of the Parent or its Affiliates.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that any action taken by Parent or any of its Affiliates shall not be deemed a Material Adverse Effect.",
        "clause_text": "provided that, no change, effect, event, occurrence or development, arising out of or resulting from any of the following shall be deemed either alone or in combination to constitute a Material Adverse Effect: ... (xiii) any action taken by Parent or any of its Affiliates;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_parent_actions_explanation",
        "answer": "The Company shall not be deemed to have suffered a Material Adverse Effect as a result of actions taken at the written direction of Parent or any action specifically required to be taken by the Company by the terms of this Agreement.",
        "summary": "Adverse effects resulting from actions taken by the Company at the written direction of Parent or as required by the Agreement are excluded from the definition of Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that actions taken at the written direction of Parent or required by the Agreement are not considered a Material Adverse Effect.",
        "clause_text": "any action taken (or failure to act) by the Company or any Company Subsidiary at the written direction of Parent or any action specifically required to be taken by the Company or any Company Subsidiary by the terms of this Agreement;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_projections_miss_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes failures to meet projections, forecasts, estimates, or internal budgets from constituting a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that the failure to meet internal, published, or analyst’s expectations, forecasts, estimates, guidance, milestones, budgets, or predictions shall not be deemed a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect means any change, effect, event, occurrence or development that, individually or in the aggregate with all other changes, effects, events, occurrences or developments, has had or would reasonably be expected to have a material adverse effect on the business condition (financial or otherwise), assets, or results of operations of the Company and the Company Subsidiaries, taken as a whole; provided that, no change, effect, event, occurrence or development, arising out of or resulting from any of the following shall be deemed either alone or in combination to constitute a Material Adverse Effect, and none of the following shall be taken into account in determining whether there is, or would reasonably likely to be, a Material Adverse Effect: ... (vi) the failure of the Company or any Company Subsidiary to meet internal, published, or analyst’s expectation, forecast, estimate, guidance, milestone, budget or prediction in respect of revenues, earnings, or other internal or published financial or operating metrics for any period (it being understood that the underlying facts or occurrences giving rise to such change may be taken into account in determining whether there has been or will be a Material Adverse Effect, to the extent not otherwise excluded from this definition);",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_projections_miss_explanation",
        "answer": "The failure of the Company or any Company Subsidiary to meet internal, published, or analyst’s expectation, forecast, estimate, guidance, milestone, budget or prediction in respect of revenues, earnings, or other internal or published financial or operating metrics for any period (it being understood that the underlying facts or occurrences giving rise to such change may be taken into account in determining whether there has been or will be a Material Adverse Effect, to the extent not otherwise excluded from this definition);",
        "summary": "Failures to meet projections, forecasts, estimates, or internal budgets are excluded from the MAE definition, though underlying facts may still be considered.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that failures to meet expectations or forecasts are not deemed a Material Adverse Effect.",
        "clause_text": "The failure of the Company or any Company Subsidiary to meet internal, published, or analyst’s expectation, forecast, estimate, guidance, milestone, budget or prediction in respect of revenues, earnings, or other internal or published financial or operating metrics for any period (it being understood that the underlying facts or occurrences giving rise to such change may be taken into account in determining whether there has been or will be a Material Adverse Effect, to the extent not otherwise excluded from this definition);",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_other_custom_items_present",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_other_custom_items",
        "answer": [
          {
            "label": "Union Activity",
            "excerpt": "any labor strike, slow down, lockage or stoppage, pending or threatened, affecting the Company or any Company Subsidiary"
          },
          {
            "label": "Regulatory Delays",
            "excerpt": "any determination by, or delay of a determination by, the FDA or any other Governmental Authority, or any panel, or advisory body empowered or appointed thereby, or any indication that any such entity, panel, or body will make any determination or delay in making any determination, with respect to any pending applications, approvals or clearances relating to the Company’s customers or their competitors’ or potential competitors’ product candidates, products, or programs"
          },
          {
            "label": "Legal Proceedings",
            "excerpt": "any Legal Proceeding based on an allegation of a breach of fiduciary duty or violation of applicable Law arising out of, relating to, or resulting from this Agreement or the Transactions"
          },
          {
            "label": "SEC Filing Delays",
            "excerpt": "the Company’s failure to file in a timely manner (a) any periodic report with the SEC (whether required to be filed prior to, on or after the date of this Agreement), including its Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2023, September 30, 2023, and December 31, 2023, and its Annual Report on Form 10-K for the fiscal year ended June 30, 2023, in each case, only to the extent arising out of the matters set forth in Item 9A in the Company’s Annual Report on Form 10-K (the “Disclosure Controls and Procedures”) for the fiscal year ended June 30, 2023 or (b) its proxy statement for its 2023 annual meeting of stockholders"
          },
          {
            "label": "Specific Disclosure Schedule Item",
            "excerpt": "the matter set forth on Section A-1(xv) of the Company Disclosure Schedule (it being understood that the underlying facts or occurrences giving rise to such change may be taken into account in determining whether there has been or will be a Material Adverse Effect, to the extent not otherwise excluded from this definition)"
          }
        ],
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "mae_carveback": [
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_disproportionate_effects_included",
        "answer": true,
        "summary": "The MAE clause specifies that carve-outs are reintroduced if the Company is disproportionately affected compared to others in its industry.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that events may be considered a Material Adverse Effect if they have a materially disproportionate adverse effect on the Company relative to other industry participants.",
        "clause_text": "provided, further, however, that any event, change, occurrence, or development referred to in the foregoing clause (iii), (iv), (v) or (x) may be taken into account in determining whether there is, or would reasonably likely to be, a Material Adverse Effect to the extent such change, effect, event, occurrence or development that has a materially disproportionate adverse effect on the Company and the Company Subsidiaries, taken as a whole, relative to other participants operating in the industries in which the Company and the Company Subsidiaries operate.",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_disproportionate_effects_explanation",
        "answer": "Yes",
        "summary": "The MAE definition includes a carve-back stating that certain carve-outs do not apply if such events have a materially disproportionate adverse effect on the Company relative to others in its industry.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions that events in clauses (iii), (iv), (v), or (x) may be considered if they have a materially disproportionate adverse effect on the Company compared to industry peers.",
        "clause_text": "provided, further, however, that any event, change, occurrence, or development referred to in the foregoing clause (iii), (iv), (v) or (x) may be taken into account in determining whether there is, or would reasonably likely to be, a Material Adverse Effect to the extent such change, effect, event, occurrence or development that has a materially disproportionate adverse effect on the Company and the Company Subsidiaries, taken as a whole, relative to other participants operating in the industries in which the Company and the Company Subsidiaries operate.",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_additional_exceptions_included",
        "answer": true,
        "summary": "The MAE clause specifies carve-outs are reintroduced under specific conditions, such as when changes have a materially disproportionate adverse effect on the Company relative to other industry participants.",
        "confidence": 0.9,
        "reason": "The clause includes language that allows for the consideration of underlying facts or occurrences and mentions disproportionate effects on the Company.",
        "clause_text": "provided, further, however, that any event, change, occurrence, or development referred to in the foregoing clause (iii), (iv), (v) or (x) may be taken into account in determining whether there is, or would reasonably likely to be, a Material Adverse Effect to the extent such change, effect, event, occurrence or development that has a materially disproportionate adverse effect on the Company and the Company Subsidiaries, taken as a whole, relative to other participants operating in the industries in which the Company and the Company Subsidiaries operate.",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_additional_exceptions_explanation",
        "answer": [
          "The underlying facts or occurrences giving rise to changes in the market price or trading volume of the Company Common Stock or the credit rating of the Company or any Company Subsidiary may be taken into account in determining whether there has been or will be a Material Adverse Effect, to the extent not otherwise excluded from this definition.",
          "The underlying facts or occurrences giving rise to the failure of the Company or any Company Subsidiary to meet internal, published, or analyst’s expectation, forecast, estimate, guidance, milestone, budget or prediction in respect of revenues, earnings, or other internal or published financial or operating metrics for any period may be taken into account in determining whether there has been or will be a Material Adverse Effect, to the extent not otherwise excluded from this definition.",
          "Any event, change, occurrence, or development referred to in clauses (iii), (iv), (v) or (x) may be taken into account in determining whether there is, or would reasonably likely to be, a Material Adverse Effect to the extent such change, effect, event, occurrence or development has a materially disproportionate adverse effect on the Company and the Company Subsidiaries, taken as a whole, relative to other participants operating in the industries in which the Company and the Company Subsidiaries operate."
        ],
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_causation_based_analysis_included",
        "answer": true,
        "summary": "The MAE definition includes language indicating that the underlying facts or occurrences giving rise to certain excluded events, such as stock price changes or failures to meet projections, may be considered in determining whether a Material Adverse Effect has occurred.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that the underlying facts or occurrences giving rise to certain changes may be taken into account in determining a Material Adverse Effect.",
        "clause_text": "it being understood that the underlying facts or occurrences giving rise to such change may be taken into account in determining whether there has been or will be a Material Adverse Effect, to the extent not otherwise excluded from this definition",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_causation_based_analysis_explanation",
        "answer": "The facts or occurrences giving rise to an excluded event may still be taken into account in determining whether a Material Adverse Effect has occurred, specifically for clauses (i) and (vi).",
        "summary": "The carve-back allows for the underlying facts or occurrences that lead to changes in stock price or failure to meet financial projections to be considered in determining a Material Adverse Effect.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that underlying facts or occurrences related to changes in stock price and financial projections can be considered.",
        "clause_text": "it being understood that the underlying facts or occurrences giving rise to such change may be taken into account in determining whether there has been or will be a Material Adverse Effect, to the extent not otherwise excluded from this definition",
        "reference_section": "Definition > Material Adverse Effect"
      }
    ]
  },
  "non_solicitation": {
    "no_shop_clause": [
      {
        "section": "non_solicitation",
        "field_name": "no_shop_clause_included",
        "answer": true,
        "summary": "The agreement includes a 'No-Shop' clause that restricts the Company from soliciting or engaging in discussions regarding alternative acquisition proposals.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that the Company shall not solicit, initiate, or engage in discussions regarding an Acquisition Proposal.",
        "clause_text": "Except as permitted by this Section 5.03, during the Pre-Closing Period, the Company shall, and shall cause the Company Subsidiaries to, and shall direct its Representatives to, cease any direct or indirect solicitation, encouragement, discussion, or negotiation with any Person that may be ongoing with respect to an Acquisition Proposal and the Company shall not, and shall direct its Representatives not to, directly or indirectly, (i) solicit, initiate, or knowingly facilitate, or knowingly encourage (including by way of furnishing non-public information) any inquiry regarding, or the making of any proposal or offer that constitutes, an Acquisition Proposal.",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.03 No Solicitation > (a)"
      },
      {
        "section": "non_solicitation",
        "field_name": "no_shop_claus_explanation",
        "answer": "During the Pre-Closing Period, the Company shall, and shall cause the Company Subsidiaries to, and shall direct its Representatives to, cease any direct or indirect solicitation, encouragement, discussion, or negotiation with any Person that may be ongoing with respect to an Acquisition Proposal and the Company shall not, and shall direct its Representatives not to, directly or indirectly, (i) solicit, initiate, or knowingly facilitate, or knowingly encourage (including by way of furnishing non-public information) any inquiry regarding, or the making of any proposal or offer that constitutes, an Acquisition Proposal, (ii) engage in, continue, or otherwise participate in any discussion or negotiation regarding, or furnish to any other Person any non-public information in connection with, or for the purpose of knowingly encouraging or knowingly facilitating, an Acquisition Proposal, or (iii) enter into any letter of intent, acquisition agreement, agreement in principle, or similar agreement with respect to an Acquisition Proposal (other than an Acceptable Confidentiality Agreement in accordance with Section 5.03(b)).",
        "summary": "The No-Shop clause prohibits the Company from soliciting, initiating, or engaging in discussions or negotiations regarding any Acquisition Proposal during the Pre-Closing Period.",
        "confidence": 0.95,
        "reason": "The clause explicitly restricts the Company from engaging in any solicitation, discussion, or negotiation regarding Acquisition Proposals.",
        "clause_text": "During the Pre-Closing Period, the Company shall, and shall cause the Company Subsidiaries to, and shall direct its Representatives to, cease any direct or indirect solicitation, encouragement, discussion, or negotiation with any Person that may be ongoing with respect to an Acquisition Proposal and the Company shall not, and shall direct its Representatives not to, directly or indirectly, (i) solicit, initiate, or knowingly facilitate, or knowingly encourage (including by way of furnishing non-public information) any inquiry regarding, or the making of any proposal or offer that constitutes, an Acquisition Proposal, (ii) engage in, continue, or otherwise participate in any discussion or negotiation regarding, or furnish to any other Person any non-public information in connection with, or for the purpose of knowingly encouraging or knowingly facilitating, an Acquisition Proposal, or (iii) enter into any letter of intent, acquisition agreement, agreement in principle, or similar agreement with respect to an Acquisition Proposal (other than an Acceptable Confidentiality Agreement in accordance with Section 5.03(b)).",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.03 No Solicitation > (a)"
      }
    ],
    "notice_of_competing_offer": [
      {
        "section": "non_solicitation",
        "field_name": "notice_of_competing_offer_included",
        "answer": true,
        "summary": "The agreement requires the Company to promptly notify Parent if any inquiry, proposal, or offer with respect to an Acquisition Proposal is received.",
        "confidence": 1.0,
        "reason": "The clause explicitly states the obligation to notify Parent within forty-eight hours of receiving an Acquisition Proposal.",
        "clause_text": "The Company shall (i) promptly (and, in any event within forty-eight (48) hours) notify Parent if any inquiry, proposal, or offer with respect to an Acquisition Proposal is received by the Company or any Company Representative, including the identity of the Person or group of Persons making such Acquisition Proposal.",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.03 No Solicitation > (c)"
      },
      {
        "section": "non_solicitation",
        "field_name": "notice_of_competing_offer_explanation",
        "answer": "The Company is required to notify Parent within forty-eight (48) hours if any inquiry, proposal, or offer with respect to an Acquisition Proposal is received, including the identity of the Person or group of Persons making such Acquisition Proposal.",
        "summary": "The Company must notify Parent within 48 hours of receiving any Acquisition Proposal, including the identity of the proposing party.",
        "confidence": 0.95,
        "reason": "The clause explicitly states the obligation to notify Parent of any Acquisition Proposal within a specified timeframe.",
        "clause_text": "The Company shall (i) promptly (and, in any event within forty-eight (48) hours) notify Parent if any inquiry, proposal, or offer with respect to an Acquisition Proposal is received by the Company or any Company Representative, including the identity of the Person or group of Persons making such Acquisition Proposal.",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.03 No Solicitation > (c)"
      }
    ],
    "ongoing_update": [
      {
        "section": "non_solicitation",
        "field_name": "ongoing_update_included",
        "answer": true,
        "summary": "The agreement requires the Company to keep Parent reasonably informed of any material development, discussion, or negotiation regarding any Acquisition Proposal on a prompt basis.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that the Company shall keep Parent reasonably informed of any material development regarding any Acquisition Proposal.",
        "clause_text": "The Company shall (i) promptly (and, in any event within forty-eight (48) hours) notify Parent if any inquiry, proposal, or offer with respect to an Acquisition Proposal is received by the Company or any Company Representative, including the identity of the Person or group of Persons making such Acquisition Proposal, (ii) promptly (and, in any event within forty-eight (48) hours) provide to Parent a copy of such Acquisition Proposal or if such Acquisition Proposal is oral, then a summary of the material terms and conditions of any such Acquisition Proposal (and any amendment thereto) and (iii) keep Parent reasonably informed of any material development, discussion, or negotiation regarding any Acquisition Proposal (and any amendment thereto) on a prompt basis.",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.03 No Solicitation > (c)"
      },
      {
        "section": "non_solicitation",
        "field_name": "ongoing_update_explanation",
        "answer": "The Company is obligated to provide ongoing updates to the Buyer about any changes in status or negotiations relating to a competing offer.",
        "summary": "The Company must notify Parent within forty-eight hours of receiving any Acquisition Proposal and keep Parent reasonably informed of any material developments regarding such proposals.",
        "confidence": 0.9,
        "reason": "The clause specifies the Company's obligation to notify Parent of any Acquisition Proposal and to keep Parent informed of material developments.",
        "clause_text": "The Company shall (i) promptly (and, in any event within forty-eight (48) hours) notify Parent if any inquiry, proposal, or offer with respect to an Acquisition Proposal is received by the Company or any Company Representative, including the identity of the Person or group of Persons making such Acquisition Proposal, (ii) promptly (and, in any event within forty-eight (48) hours) provide to Parent a copy of such Acquisition Proposal or if such Acquisition Proposal is oral, then a summary of the material terms and conditions of any such Acquisition Proposal (and any amendment thereto) and (iii) keep Parent reasonably informed of any material development, discussion, or negotiation regarding any Acquisition Proposal (and any amendment thereto) on a prompt basis.",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.03 No Solicitation > (c)"
      }
    ],
    "superior_proposal_engagement": [
      {
        "section": "non_solicitation",
        "field_name": "superior_proposal_engagement_included",
        "answer": true,
        "summary": "The agreement permits the Company to engage in discussions or negotiations with a third party that submits a Superior Proposal under certain conditions.",
        "confidence": 0.9,
        "reason": "The agreement allows the Company to engage in discussions or negotiations with a third party that submits a Superior Proposal, provided certain conditions are met, such as entering into an Acceptable Confidentiality Agreement and notifying the Parent.",
        "clause_text": "(b) Notwithstanding anything to the contrary in this Agreement, if, at any time prior to the time the Required Company Stockholder Vote is obtained, the Company or any Company Representative receives an Acquisition Proposal from any Person or group of Persons, which Acquisition Proposal was made on or after the date of this Agreement and did not result from a material breach of this Section 5.03, (i) the Company and its Representatives may contact such Person or group of Persons to clarify the terms and conditions thereof and inform such Person or group of Persons of the terms of this Section 5.03 and (ii) if the Company Board determines in good faith, after consultation with its outside legal counsel and financial advisors, that such Acquisition Proposal constitutes, or could reasonably be expected to lead to, a Superior Offer, then the Company and its Representatives may (A) negotiate and enter into an Acceptable Confidentiality Agreement with the Person or Persons making such Acquisition Proposal and furnish, pursuant to any such Acceptable Confidentiality Agreement, information (including non-public information) with respect to the Company to the Person or group of Persons who has made such Acquisition Proposal and their potential sources of financing and their respective Representatives; provided that (x) the Company shall substantially concurrently (and in any event within forty-eight (48) hours) provide to Parent all information concerning the Company that is provided to any such Person and was not previously provided to Parent or its Representatives and (y) any competitively sensitive information or data provided to such Person will be provided in a separate 'clean team room' and subject to customary 'clean team' arrangements regarding access to such information or data, as reasonably determined by the Company with advice from its outside legal counsel, and (B) engage in or otherwise participate in discussions or negotiations with the Person or group of Persons making such Acquisition Proposal and their potential sources of financing and their respective Representatives.",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.03 No Solicitation > (b)"
      },
      {
        "section": "non_solicitation",
        "field_name": "superior_proposal_engagement_explanation",
        "answer": "The Company is authorized to engage with third parties if a Superior Proposal is received, provided the Company Board determines in good faith that the proposal constitutes or could lead to a Superior Offer, and after consultation with legal and financial advisors.",
        "summary": "The Company may negotiate or share information with third parties if a Superior Proposal is received, based on the Company Board's good faith determination.",
        "confidence": 0.9,
        "reason": "The clause allows engagement with third parties if the Company Board determines in good faith that the proposal is a Superior Offer.",
        "clause_text": "if the Company Board determines in good faith, after consultation with its outside legal counsel and financial advisors, that such Acquisition Proposal constitutes, or could reasonably be expected to lead to, a Superior Offer, then the Company and its Representatives may (A) negotiate and enter into an Acceptable Confidentiality Agreement with the Person or Persons making such Acquisition Proposal and furnish, pursuant to any such Acceptable Confidentiality Agreement, information (including non-public information) with respect to the Company to the Person or group of Persons who has made such Acquisition Proposal and their potential sources of financing and their respective Representatives; provided that (x) the Company shall substantially concurrently (and in any event within forty-eight (48) hours) provide to Parent all information concerning the Company that is provided to any such Person and was not previously provided to Parent or its Representatives and (y) any competitively sensitive information or data provided to such Person will be provided in a separate \"clean team room\" and subject to customary \"clean team\" arrangements regarding access to such information or data, as reasonably determined by the Company with advice from its outside legal counsel, and (B) engage in or otherwise participate in discussions or negotiations with the Person or group of Persons making such Acquisition Proposal and their potential sources of financing and their respective Representatives.",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.03 No Solicitation > (b)"
      }
    ],
    "match_right": [
      {
        "section": "non_solicitation",
        "field_name": "match_right_initial_included",
        "answer": true,
        "summary": "The agreement grants the buyer a right to match an initial Superior Proposal by allowing Parent a five-day period to propose revisions or make another proposal after receiving a Determination Notice.",
        "confidence": 0.9,
        "reason": "The agreement explicitly provides Parent with a five-day period to propose revisions or make another proposal following a Determination Notice of a Superior Offer.",
        "clause_text": "The Company shall have given Parent the five (5) day period after the delivery of a Determination Notice to propose revisions to the terms of this Agreement or make another proposal, and shall have made its Representatives reasonably available to negotiate in good faith with Parent (to the extent Parent desires to negotiate) with respect to such proposed revisions or other proposal, if any.",
        "reference_section": "ARTICLE VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.01 Company Board Recommendation > (b)(i)(D)(2)"
      },
      {
        "section": "non_solicitation",
        "field_name": "match_right_initial_explanation",
        "answer": "The Company shall have given Parent the five (5) day period after the delivery of a Determination Notice to propose revisions to the terms of this Agreement or make another proposal, and shall have made its Representatives reasonably available to negotiate in good faith with Parent (to the extent Parent desires to negotiate) with respect to such proposed revisions or other proposal, if any.",
        "summary": "The clause provides the Buyer a five-day period to revise its offer after receiving a Superior Proposal, with an obligation for the Company to negotiate in good faith.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions a five-day period for the Buyer to propose revisions, fulfilling the requirement for a negotiation period after a Superior Proposal.",
        "clause_text": "The Company shall have given Parent the five (5) day period after the delivery of a Determination Notice to propose revisions to the terms of this Agreement or make another proposal, and shall have made its Representatives reasonably available to negotiate in good faith with Parent (to the extent Parent desires to negotiate) with respect to such proposed revisions or other proposal, if any.",
        "reference_section": "ARTICLE VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.01 Company Board Recommendation > (b) > (i) > (D) (2)"
      },
      {
        "section": "non_solicitation",
        "field_name": "match_right_amended_included",
        "answer": true,
        "summary": "The agreement provides that the provisions for a Superior Offer apply to any material amendment to an Acquisition Proposal, requiring a new Determination Notice and compliance with negotiation clauses.",
        "confidence": 0.9,
        "reason": "The agreement explicitly states that material amendments to an Acquisition Proposal require a new Determination Notice and compliance with negotiation clauses, indicating a renewed right to match.",
        "clause_text": "The provisions of this Section 6.01(b)(i) shall also apply to any material amendment to any Acquisition Proposal, which shall require a new Determination Notice and compliance with clause (D) above, except that, in each case, the references to five (5) days shall be deemed to be three (3) days;",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.01 Company Board Recommendation > (b)(i)"
      },
      {
        "section": "non_solicitation",
        "field_name": "match_right_amended_explanation",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "adverse_recommendation_change": [
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_superior_proposal_included",
        "answer": true,
        "summary": "The board of directors is permitted to make an adverse recommendation change in response to a Superior Proposal if certain conditions are met.",
        "confidence": 0.95,
        "reason": "The document explicitly states that the Company Board may make a Company Adverse Change Recommendation if the Acquisition Proposal is determined to be a Superior Offer.",
        "clause_text": "(b) Notwithstanding anything to the contrary in this Agreement, at any time prior to the time the Required Company Stockholder Vote is obtained, and subject to compliance with the other provisions of this Section 6.01: (i) if the Company has received a written Acquisition Proposal (which Acquisition Proposal did not result from a material breach of Section 5.03) from any Person, and such Acquisition Proposal has not been withdrawn, (x) the Company Board may make a Company Adverse Change Recommendation...",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.01 Company Board Recommendation > (b) > (i)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_superior_proposal_explanation",
        "answer": "The Company Board is permitted to change its recommendation in response to a Superior Proposal.",
        "summary": "The Company Board may change its recommendation if it determines in good faith, after consulting with financial advisors and legal counsel, that an Acquisition Proposal is a Superior Offer and failure to change the recommendation would be inconsistent with fiduciary duties.",
        "confidence": 0.95,
        "reason": "The clause explicitly states the conditions under which the Company Board can change its recommendation, including good faith determination and consultation with advisors.",
        "clause_text": "(b) Notwithstanding anything to the contrary in this Agreement, at any time prior to the time the Required Company Stockholder Vote is obtained, and subject to compliance with the other provisions of this Section 6.01: (i) if the Company has received a written Acquisition Proposal (which Acquisition Proposal did not result from a material breach of Section 5.03) from any Person, and such Acquisition Proposal has not been withdrawn, (x) the Company Board may make a Company Adverse Change Recommendation or (y) the Company may terminate this Agreement pursuant to Section 8.01(g) to enter into a binding written definitive acquisition agreement providing for such Acquisition Proposal, in each case, if and only if: (A) the Company Board determines in good faith, after consultation with financial advisors and outside legal counsel, that such Acquisition Proposal is a Superior Offer; (B) the Company Board determines in good faith, after consultation with outside legal counsel, that the failure to do so would be reasonably expected to be inconsistent with the fiduciary duties of the Company Board to the Company's stockholders under applicable Law;",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.01 Company Board Recommendation > (b)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_intervening_event_included",
        "answer": true,
        "summary": "The Company Board is permitted to make a Company Adverse Change Recommendation in response to a Change in Circumstance, which is defined as an event not known or foreseeable at signing.",
        "confidence": 0.95,
        "reason": "The agreement explicitly allows for a Company Adverse Change Recommendation in response to a Change in Circumstance, which includes unforeseen events.",
        "clause_text": "other than in connection with an Acquisition Proposal, the Company Board may make a Company Adverse Change Recommendation in response to a Change in Circumstance, if and only if: (A) the Company Board determines in good faith, after consultation with outside legal counsel, that the failure to do so would be reasonably expected to be inconsistent with the fiduciary duties of the Company Board to the Company's stockholders under applicable Law;",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.01 Company Board Recommendation > (b) > (ii)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_intervening_event_explanation",
        "answer": "The Company Board may make a Company Adverse Change Recommendation in response to a Change in Circumstance, if and only if: (A) the Company Board determines in good faith, after consultation with outside legal counsel, that the failure to do so would be reasonably expected to be inconsistent with the fiduciary duties of the Company Board to the Company's stockholders under applicable Law; (B) the Company shall have given Parent a Determination Notice at least five (5) days prior to making any such Company Adverse Change Recommendation; and (C) (1) the Company shall have specified the Change in Circumstance in reasonable detail, (2) the Company shall have given Parent the five (5) day period after the delivery of a Determination Notice to propose revisions to the terms of this Agreement or make another proposal, and shall have made its Representatives reasonably available to negotiate in good faith with Parent (to the extent Parent desires to negotiate) with respect to such proposed revisions or other proposal, if any, and (3) after considering the outcome of any such negotiation and giving effect to any binding commitment made in writing by Parent, after consultation with outside legal counsel, the Company Board shall have determined, in good faith, that the failure to make the Company Adverse Change Recommendation in response to such Change in Circumstance would be reasonably expected to be inconsistent with the fiduciary duties of the Company Board to the Company's stockholders under applicable Law.",
        "summary": "The Company Board can change its recommendation due to a Change in Circumstance if it determines in good faith that not doing so would breach fiduciary duties, after notifying Parent and allowing negotiation.",
        "confidence": 0.95,
        "reason": "The clause explicitly allows for a recommendation change due to a Change in Circumstance, meeting the criteria of an Intervening Event.",
        "clause_text": "The Company Board may make a Company Adverse Change Recommendation in response to a Change in Circumstance, if and only if: (A) the Company Board determines in good faith, after consultation with outside legal counsel, that the failure to do so would be reasonably expected to be inconsistent with the fiduciary duties of the Company Board to the Company's stockholders under applicable Law; (B) the Company shall have given Parent a Determination Notice at least five (5) days prior to making any such Company Adverse Change Recommendation; and (C) (1) the Company shall have specified the Change in Circumstance in reasonable detail, (2) the Company shall have given Parent the five (5) day period after the delivery of a Determination Notice to propose revisions to the terms of this Agreement or make another proposal, and shall have made its Representatives reasonably available to negotiate in good faith with Parent (to the extent Parent desires to negotiate) with respect to such proposed revisions or other proposal, if any, and (3) after considering the outcome of any such negotiation and giving effect to any binding commitment made in writing by Parent, after consultation with outside legal counsel, the Company Board shall have determined, in good faith, that the failure to make the Company Adverse Change Recommendation in response to such Change in Circumstance would be reasonably expected to be inconsistent with the fiduciary duties of the Company Board to the Company's stockholders under applicable Law.",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.01 Company Board Recommendation > (b) > (ii)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_timing",
        "answer": "The Company Board must provide Parent with a Determination Notice at least five (5) days prior to making any Company Adverse Change Recommendation.",
        "summary": "The Company Board is required to give Parent a Determination Notice at least five days before making an Adverse Recommendation Change.",
        "confidence": 0.9,
        "reason": "The clause specifies a five-day notice period before the Company Board can make an Adverse Recommendation Change.",
        "clause_text": "The Company shall have given Parent prior written notice of its intention to make a Company Adverse Change Recommendation or terminate this Agreement pursuant to Section 8.01(g) at least five (5) days prior to making any such Company Adverse Change Recommendation or termination (a 'Determination Notice').",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.01 Company Board Recommendation > (b) > (i)"
      }
    ],
    "go_shop": [
      {
        "section": "non_solicitation",
        "field_name": "go_shop_included",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "non_solicitation",
        "field_name": "go_shop_explanation",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "standstill_waiver_restriction": [
      {
        "section": "non_solicitation",
        "field_name": "standstill_waiver_restriction_included",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "non_solicitation",
        "field_name": "standstill_waiver_restriction_explanation",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "superior_proposal": [
      {
        "section": "non_solicitation",
        "field_name": "superior_proposal_definition",
        "answer": "Superior Offer means any Acquisition Proposal that the Company Board determines, in its good faith judgment, after consultation with financial advisors and outside legal counsel, taking into account all factors that the Company Board deems relevant (including, for the avoidance of doubt, the relevant regulatory and financial aspects of such Acquisition Proposal, including the likelihood such Acquisition Proposal is to be consummated), if consummated, would result in a transaction more favorable to the Company's stockholders than the Transactions; provided that, for purposes of this definition of 'Superior Offer,' the references to 'twenty percent (20%) or more' in the definition of Acquisition Proposal shall be deemed to be references to 'more than fifty percent (50%).'",
        "summary": "A 'Superior Offer' is an Acquisition Proposal deemed more favorable to the Company's stockholders than the current Transactions, considering financial and regulatory aspects and the likelihood of consummation.",
        "confidence": 0.95,
        "reason": "The definition explicitly outlines the criteria for a 'Superior Offer,' including financial and non-financial elements.",
        "clause_text": "Superior Offer means any Acquisition Proposal that the Company Board determines, in its good faith judgment, after consultation with financial advisors and outside legal counsel, taking into account all factors that the Company Board deems relevant (including, for the avoidance of doubt, the relevant regulatory and financial aspects of such Acquisition Proposal, including the likelihood such Acquisition Proposal is to be consummated), if consummated, would result in a transaction more favorable to the Company's stockholders than the Transactions; provided that, for purposes of this definition of 'Superior Offer,' the references to 'twenty percent (20%) or more' in the definition of Acquisition Proposal shall be deemed to be references to 'more than fifty percent (50%).'",
        "reference_section": "Definition > Superior Offer"
      }
    ],
    "buyer_diligence_access": [
      {
        "section": "non_solicitation",
        "field_name": "buyer_diligence_access_included",
        "answer": true,
        "summary": "The agreement grants the buyer the right to receive any diligence materials shared with a third party.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the Company shall provide to Parent all information concerning the Company that is provided to any such Person and was not previously provided to Parent or its Representatives.",
        "clause_text": "provided that (x) the Company shall substantially concurrently (and in any event within forty-eight (48) hours) provide to Parent all information concerning the Company that is provided to any such Person and was not previously provided to Parent or its Representatives",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.03 No Solicitation > (b)"
      },
      {
        "section": "non_solicitation",
        "field_name": "buyer_diligence_access_explanation",
        "answer": "The Company shall substantially concurrently (and in any event within forty-eight (48) hours) provide to Parent all information concerning the Company that is provided to any such Person and was not previously provided to Parent or its Representatives.",
        "summary": "The Company is obligated to provide Parent with any information shared with a third party in connection with an Acquisition Proposal within 48 hours.",
        "confidence": 0.95,
        "reason": "The clause explicitly states the Company's obligation to provide Parent with information shared with third parties.",
        "clause_text": "The Company shall substantially concurrently (and in any event within forty-eight (48) hours) provide to Parent all information concerning the Company that is provided to any such Person and was not previously provided to Parent or its Representatives.",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.03 No Solicitation > (b)"
      }
    ],
    "recommendation_change_restriction": [
      {
        "section": "non_solicitation",
        "field_name": "recommendation_change_restriction_included",
        "answer": true,
        "summary": "The agreement imposes restrictions on the board's communication of a change in recommendation, requiring prior notice to the Parent and allowing time for negotiation.",
        "confidence": 0.95,
        "reason": "The agreement requires the Company to give Parent prior written notice and a period for negotiation before making a Company Adverse Change Recommendation.",
        "clause_text": "(b) Notwithstanding anything to the contrary in this Agreement, at any time prior to the time the Required Company Stockholder Vote is obtained, and subject to compliance with the other provisions of this Section 6.01: (i) if the Company has received a written Acquisition Proposal... (C) the Company shall have given Parent prior written notice of its intention to make a Company Adverse Change Recommendation... at least five (5) days prior to making any such Company Adverse Change Recommendation...",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.01 Company Board Recommendation > (b)"
      },
      {
        "section": "non_solicitation",
        "field_name": "recommendation_change_restriction_explanation",
        "answer": "The agreement imposes procedural and timing-based restrictions on how the Company may change its recommendation. The Company must provide Parent with a Determination Notice at least five days prior to making a Company Adverse Change Recommendation or terminating the agreement. During this period, the Company must negotiate in good faith with Parent, allowing Parent to propose revisions to the agreement.",
        "summary": "The Company must provide a Determination Notice to Parent at least five days before changing its recommendation, allowing for good faith negotiations.",
        "confidence": 0.9,
        "reason": "The clause specifies a five-day notice period and negotiation requirement before a recommendation change.",
        "clause_text": "(C) the Company shall have given Parent prior written notice of its intention to make a Company Adverse Change Recommendation or terminate this Agreement pursuant to Section 8.01(g) at least five (5) days prior to making any such Company Adverse Change Recommendation or termination (a \"Determination Notice\") (which notice shall not constitute a Company Adverse Change Recommendation); and (D) (1) the Company shall have provided to Parent a copy of such Acquisition Proposal containing the terms and conditions of the Acquisition Proposal in accordance with Section 5.03(c), (2) the Company shall have given Parent the five (5) day period after the delivery of a Determination Notice to propose revisions to the terms of this Agreement or make another proposal, and shall have made its Representatives reasonably available to negotiate in good faith with Parent (to the extent Parent desires to negotiate) with respect to such proposed revisions or other proposal, if any, and (3) after considering the outcome of any such negotiation and giving effect to any binding commitment made in writing by Parent, the Company Board shall have determined, in good faith, after consultation with financial advisors and outside legal counsel, that that such Acquisition Proposal is a Superior Offer and, after consultation with outside legal counsel, that the failure to make a Company Adverse Change Recommendation or terminate this Agreement pursuant to Section 8.01(g) to enter into a binding written definitive acquisition agreement providing for such Acquisition Proposal would be reasonably expected to be inconsistent with the fiduciary duties of the Company Board to the Company's stockholders under applicable Law.",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.01 Company Board Recommendation > (b)(i)"
      }
    ]
  },
  "best_efforts": {
    "regulatory_efforts": [
      {
        "section": "best_efforts",
        "field_name": "effort_standard",
        "answer": "Reasonable Best Efforts",
        "summary": "The parties are required to use their reasonable best efforts to obtain regulatory approvals and take necessary actions to consummate the transactions as promptly as practicable.",
        "confidence": 0.9,
        "reason": "The term 'reasonable best efforts' is explicitly used in multiple sections, indicating the standard of effort required.",
        "clause_text": "each of Parent, Merger Sub, and the Company and the members of their respective boards of directors shall use their respective reasonable best efforts to grant such approvals, and take such actions as are necessary so that the Transactions may be consummated as promptly as practicable",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.07 Takeover Laws"
      },
      {
        "section": "best_efforts",
        "field_name": "effort_scope",
        "answer": "RBE for HSR, CMA, and other Requisite Regulatory Approvals",
        "summary": "The effort scope includes obtaining necessary approvals under the HSR Act, CMA, and other Requisite Regulatory Approvals related to Antitrust Laws.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions the HSR Act, CMA, and other Requisite Regulatory Approvals in connection with Antitrust Laws.",
        "clause_text": "Subject to the terms and conditions of this Agreement, each Party shall (and shall cause their respective controlled Affiliates, if applicable, to) as promptly as reasonably practicable, but in no event later than twenty (20) business days after the date of this Agreement (subject to the receipt by Parent from the Company of any information required to complete the applicable filing, notification or other consent that is requested by Parent), (i) make an appropriate filing of all Notification and Report forms as required by the HSR Act with respect to the Transactions, and (ii) initiate the regulatory process before any other Governmental Authority in connection with any Requisite Regulatory Approvals and the CMA with a view to submitting filings, or draft filings as appropriate, and a CMA Briefing Paper as promptly as reasonably practicable;",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.02 Filings, Consents, and Approvals > (c)"
      }
    ],
    "regulatory_fillings_hsr": [
      {
        "section": "best_efforts",
        "field_name": "hsr_required",
        "answer": true,
        "summary": "The parties are obligated to make filings under the HSR Act, and the expiration or early termination of the HSR waiting period is a condition to closing.",
        "confidence": 0.95,
        "reason": "The document explicitly states that the parties must make filings as required by the HSR Act and that the expiration of the HSR waiting period is a condition to closing.",
        "clause_text": "Subject to the terms and conditions of this Agreement, each Party shall (and shall cause their respective controlled Affiliates, if applicable, to) as promptly as reasonably practicable, but in no event later than twenty (20) business days after the date of this Agreement (subject to the receipt by Parent from the Company of any information required to complete the applicable filing, notification or other consent that is requested by Parent), (i) make an appropriate filing of all Notification and Report forms as required by the HSR Act with respect to the Transactions.",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.02 Filings, Consents, and Approvals > (c)"
      },
      {
        "section": "best_efforts",
        "field_name": "hsr_filing_deadline_days",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "hsr_notes",
        "answer": "Must file within 20 business days of the agreement date; filing required under HSR Act as a condition to closing.",
        "summary": "Must file within 20 business days of the agreement date; filing required under HSR Act as a condition to closing.",
        "confidence": 0.9,
        "reason": "The document specifies a 20 business day deadline for HSR Act filings, which are necessary for closing.",
        "clause_text": "Subject to the terms and conditions of this Agreement, each Party shall (and shall cause their respective controlled Affiliates, if applicable, to) as promptly as reasonably practicable, but in no event later than twenty (20) business days after the date of this Agreement (subject to the receipt by Parent from the Company of any information required to complete the applicable filing, notification or other consent that is requested by Parent), (i) make an appropriate filing of all Notification and Report forms as required by the HSR Act with respect to the Transactions.",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.02 Filings, Consents, and Approvals > (c)"
      }
    ],
    "regulatory_fillings_cfiius": [
      {
        "section": "best_efforts",
        "field_name": "cfiius_required",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "cfiius_filing_deadline_days",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "cfiius_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "regulatory_fillings_foreign": [
      {
        "section": "best_efforts",
        "field_name": "foreign_filling_notes",
        "answer": "Foreign filings may be required under applicable non-U.S. laws",
        "summary": "The agreement includes obligations to make necessary filings under applicable Antitrust Laws, which encompass non-U.S. laws and regulations.",
        "confidence": 0.9,
        "reason": "The definition of Antitrust Laws includes non-U.S. laws, implying foreign filing obligations.",
        "clause_text": "Antitrust Laws means (a) the Sherman Act, the Clayton Act, the HSR Act, the Federal Trade Commission Act, state antitrust Laws, and all other applicable Law and regulations (including non-U.S. Laws and regulations) issued by a Governmental Authority that are designed or intended to preserve or protect competition...",
        "reference_section": "Definition > Antitrust Laws"
      },
      {
        "section": "best_efforts",
        "field_name": "foreign_filling_required",
        "answer": true,
        "summary": "The agreement requires filings under non-U.S. antitrust or merger control laws as it references obligations under 'other applicable Antitrust Laws,' which include non-U.S. laws.",
        "confidence": 0.9,
        "reason": "The definition of 'Antitrust Laws' includes non-U.S. laws and regulations, implying the necessity for foreign filings.",
        "clause_text": "Antitrust Laws means (a) the Sherman Act, the Clayton Act, the HSR Act, the Federal Trade Commission Act, state antitrust Laws, and all other applicable Law and regulations (including non-U.S. Laws and regulations) issued by a Governmental Authority that are designed or intended to preserve or protect competition...",
        "reference_section": "Definition > Antitrust Laws"
      },
      {
        "section": "best_efforts",
        "field_name": "foreign_filling_deadline_days",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "divestiture_commitments": [
      {
        "section": "best_efforts",
        "field_name": "divestiture_required",
        "answer": true,
        "summary": "The agreement contains obligations for the parties to take actions, including divestitures and other structural or conduct remedies, to secure regulatory approvals and resolve objections from governmental authorities.",
        "confidence": 0.9,
        "reason": "The agreement explicitly mentions actions such as divestiture, licensing, and other remedies to secure regulatory approvals.",
        "clause_text": "including, in each case, (i) negotiating, committing to, and effecting, by consent decree, hold separate order, or otherwise, the sale, lease, license, divestiture, or disposition of any asset, right, Contract, product line, product, technology or business of the Company, Parent, or any of their respective controlled Affiliates,",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.02 Filings, Consents, and Approvals > (b)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_value",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_unit",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_basis",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_basis_scope",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_clause_reference",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_value",
        "answer": "ARTICLE VI – Covenants and Agreements > Section 6.4 – Appropriate Action; Consents; Filings > (a) > (i)",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_unit",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_basis",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_basis_scope",
        "answer": "Parent",
        "summary": "The divestiture cap applies to the operations or assets of the Parent, Merger Sub, or any of their respective Affiliates.",
        "confidence": 0.9,
        "reason": "The definition of 'Parent Parties' includes Parent, Merger Sub, and their Affiliates, indicating that the divestiture cap applies to these entities.",
        "clause_text": "Parent Parties means Parent, Merger Sub, or any of their respective current, former, or future stockholders, optionholders, members, Representatives, or Affiliates.",
        "reference_section": "Definition > Parent Parties"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_clause_reference",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_scope_exclusions",
        "answer": [
          "Carve-Out Business"
        ],
        "summary": "The Carve-Out Business, which includes facilities and related businesses in Bloomington, Indiana, Brussels, Belgium, and Anagni, Italy, is explicitly defined and likely excluded from divestiture commitments.",
        "confidence": 0.9,
        "reason": "The definition of 'Carve-Out Business' suggests these facilities are set aside for specific treatment, implying exclusion from divestiture.",
        "clause_text": "Carve-Out Business means those facilities and related businesses maintained by the Company in (1) Bloomington, Indiana, (2) Brussels, Belgium, and (3) Anagni, Italy, including all Owned Real Property, Leased Real Property and other related assets associated therewith.",
        "reference_section": "Definition > Carve-Out Business"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_clause_summary",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_clause_summary_clause_reference",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "litigation_commitments": [
      {
        "section": "best_efforts",
        "field_name": "litigation_requirement_status",
        "answer": "No Mention",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "litigation_clause_scope",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "required_to_litigate_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "withdrawal_and_timing_controls_withdrawal": [
      {
        "section": "best_efforts",
        "field_name": "withdrawal_control_type",
        "answer": "mutual_consent_required",
        "summary": "The withdrawal of regulatory filings requires mutual consent as disagreements are resolved through escalating discussions between the parties' General Counsels, CFOs, and CEOs, with the final determination made by Parent after considering the Company's input.",
        "confidence": 0.9,
        "reason": "The agreement specifies a process for resolving disagreements involving regulatory filings, indicating mutual consent is required.",
        "clause_text": "provided, however, that in the event of any disagreement between the Parties with respect to the matters described in the foregoing clause (i), (ii) or (iii), the Parties' respective General Counsels shall seek to resolve such disagreement reasonably and in good faith; provided that if the General Counsels of the Parties cannot resolve any such disagreement, the Parties' respective Chief Financial Officers shall seek to resolve such disagreement reasonably and in good faith; provided, further, that if the Chief Financial Officers of the Parties cannot resolve any such disagreement, the Parties' respective Chief Executive Officers shall seek to resolve such disagreement reasonably and in good faith; provided, further, that if the Chief Executive Officers of the Parties cannot resolve any such disagreement, the final determination as to the appropriate course of action shall be made by Parent, acting reasonably after considering the comments and advice of the Company and its Representatives in good faith.",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.02 Filings, Consents, and Approvals > (e)"
      },
      {
        "section": "best_efforts",
        "field_name": "withdrawal_control_type_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "withdrawal_and_timing_controls_timing": [
      {
        "section": "best_efforts",
        "field_name": "timing_agreement_restriction",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "timing_agreement_restriction_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "remedy_actions_other": [
      {
        "section": "best_efforts",
        "field_name": "remedy_definitions_provided",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "remedy_definition_text",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "remedy_definition_text_clause_reference",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "transaction_interference": [
      {
        "section": "best_efforts",
        "field_name": "restriction_on_other_transactions",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "interference_clause_text",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "interference_clause_text_clause_reference",
        "answer": "Article VI > Section 6.02",
        "summary": "The agreement outlines obligations to avoid actions that delay or obstruct regulatory review or merger clearance in Article VI, Section 6.02.",
        "confidence": 0.95,
        "reason": "Section 6.02 explicitly details the parties' obligations to take all necessary actions to obtain regulatory approvals and avoid legal proceedings that could delay the closing.",
        "clause_text": "Upon the terms and subject to the conditions set forth in this Agreement, each of the Parties shall, and shall cause their respective controlled Affiliates to, take, or cause to be taken, all actions, to file, or cause to be filed, all documents, and to do, or cause to be done, and to assist and cooperate with the other Parties in doing, all things necessary, proper, or advisable to consummate and make effective the Transactions as soon as reasonably practicable...",
        "reference_section": "ARTICLE VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.02 Filings, Consents, and Approvals"
      }
    ],
    "second_request_certification": [
      {
        "section": "best_efforts",
        "field_name": "second_request_certification_deadline_specified",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "second_request_certification_certification_timeline_notes",
        "answer": "as promptly as reasonably practicable",
        "summary": "The timeline for certifying compliance with a Second Request under the HSR Act or for making HSR-related filings is to be completed as promptly as reasonably practicable.",
        "confidence": 0.9,
        "reason": "The phrase 'as promptly as reasonably practicable' is used in the context of regulatory filings and governmental cooperation, which implies the timeline for HSR-related actions.",
        "clause_text": "Each Party shall supply as promptly as practicable such information, documentation, other material, or testimony that may be requested by any Governmental Authority, including by complying at the earliest reasonably practicable date with any request for additional information, documents, or other materials, including any 'second request' under the HSR Act, received by any Party or any of their respective Subsidiaries from any Governmental Authority in connection with such applications or filings for the Transactions.",
        "reference_section": "ARTICLE VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.02 Filings, Consents, and Approvals > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "second_request_certification_responsibility_party",
        "answer": "Both",
        "summary": "Both parties are responsible for certifying compliance with the Second Request under the HSR Act, as they are required to cooperate and coordinate in making necessary filings and obtaining approvals.",
        "confidence": 0.9,
        "reason": "The agreement specifies that each party must cooperate and assist the other in making necessary filings and obtaining approvals, implying joint responsibility.",
        "clause_text": "Each Party shall supply as promptly as practicable such information, documentation, other material, or testimony that may be requested by any Governmental Authority, including by complying at the earliest reasonably practicable date with any request for additional information, documents, or other materials, including any 'second request' under the HSR Act, received by any Party or any of their respective Subsidiaries from any Governmental Authority in connection with such applications or filings for the Transactions.",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.02 Filings, Consents, and Approvals > (d)"
      }
    ],
    "ftc_warning_letter_handling": [
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_addressed",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_notes",
        "answer": "Not addressed",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_effect_on_closing_condition",
        "answer": "Silent",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_addressed_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "other_timing_controls": [
      {
        "section": "best_efforts",
        "field_name": "other_timing_controls_deadlines_specified",
        "answer": [
          "Company Stockholders' Meeting to occur within 45 days following the mailing of the Proxy Statement.",
          "Adjournments, recesses, or postponements of the Company Stockholders' Meeting shall be for periods of no more than 10 business days each unless agreed in writing by the Company and Parent.",
          "The written consent of Parent is required for adjournment, recess, or postponement beyond two occasions."
        ],
        "summary": "The agreement specifies deadlines for the Company Stockholders' Meeting and limits on adjournments or postponements.",
        "confidence": 0.9,
        "reason": "The agreement explicitly states timing obligations for the Company Stockholders' Meeting and conditions for adjournments.",
        "clause_text": "Subject to the other provisions of this Agreement, the Company shall (i) take all action required by the DGCL and the Company's Certificate of Incorporation and Bylaws to establish a record date for, duly call, give notice of, convene, and hold a meeting of its stockholders, within forty-five (45) days (or such other time that the Company and Parent should mutually agree) following the mailing of the Proxy Statement (the \"Company Stockholders' Meeting\")... provided that, unless agreed in writing by the Company and Parent, all such adjournments, recesses, or postponements shall be for periods of no more than ten (10) business days each...",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.05 Company Stockholders’ Meeting"
      }
    ],
    "novel_or_unstructured_regulatory_clauses": [
      {
        "section": "best_efforts",
        "field_name": "novel_or_unstructured_regulatory_clauses_items",
        "answer": [
          {
            "summary": "The Company and its Subsidiaries must not settle or compromise any Legal Proceeding by a Governmental Authority related to Requisite Regulatory Approvals or Antitrust Laws without Parent's prior written consent.",
            "section_or_clause_reference": "ARTICLE VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.02 Filings, Consents, and Approvals > (b)",
            "review_required": true
          },
          {
            "summary": "The Company must notify Parent of any Regulatory Matter that could materially and adversely affect the Carve-Out Business or the Company and its Subsidiaries, and provide Parent with a reasonable opportunity to review and comment on responses.",
            "section_or_clause_reference": "ARTICLE VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.02 Filings, Consents, and Approvals > (g)",
            "review_required": true
          }
        ],
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "prior_approval_commitment": [
      {
        "section": "best_efforts",
        "field_name": "prior_approval_commitment_addressed",
        "answer": true,
        "summary": "The agreement includes an obligation to obtain prior approval from a Governmental Authority for future transactions.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions the requirement to provide prior notice to, or obtain prior approval from, any Governmental Authority with respect to any transaction.",
        "clause_text": "including, in each case, (i) negotiating, committing to, and effecting, by consent decree, hold separate order, or otherwise, the sale, lease, license, divestiture, or disposition of any asset, right, Contract, product line, product, technology or business of the Company, Parent, or any of their respective controlled Affiliates, (ii) terminating any existing relationship, contractual right, or obligation of the Company, Parent, or any of their respective controlled Affiliates, (iii) terminating any venture or other arrangement, (iv) creating any relationship, contractual right, or obligation of the Company, Parent, or any of their respective controlled Affiliates, (v) effectuating any other change or restructuring of the Company, Parent, or any of their respective controlled Affiliates, (vi) undertaking or agreeing to (or requesting or authorizing the Company or any Company Subsidiary to undertake, effective upon the Closing) any requirement or obligation to provide prior notice to, or obtain prior approval from, any Governmental Authority with respect to any transaction or any other matter, and (vii) otherwise taking or committing to take any action with respect to, or restricting the operations of, the assets, rights, Contracts, product lines, products, technologies, or businesses of the Company, Parent, or any of their respective controlled Affiliates;",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.02 Filings, Consents, and Approvals > (b)"
      },
      {
        "section": "best_efforts",
        "field_name": "prior_approval_commitment_obligations_summary",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "prior_approval_commitment_clause_reference",
        "answer": "Section 6.02(b)",
        "summary": "Section 6.02(b) requires parties to take actions to obtain approvals and avoid legal proceedings, including obtaining prior approval from any Governmental Authority for future transactions.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions the requirement to obtain prior approval from Governmental Authorities for future transactions.",
        "clause_text": "Without limiting the obligations imposed under Section 6.02(a), the Parties shall promptly take, and cause their controlled Affiliates to take, all actions and steps requested or required (A) by any Governmental Authority as an inducement or condition to granting any actions or nonactions, waivers, consents, clearances, decisions, declarations, approvals, and the lapse of waiting periods and to resolve objections, if any, as the FTC, the DOJ, or any other Governmental Authority for which any actions or nonactions, waivers, consents, clearances, decisions, declarations, approvals, and the lapse of waiting periods is sought with respect to the Transactions...",
        "reference_section": "ARTICLE VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.02 Filings, Consents, and Approvals > (b)"
      }
    ],
    "regulatory_process_control_discretion": [
      {
        "section": "best_efforts",
        "field_name": "regulatory_process_control_discretion",
        "answer": "Parent",
        "summary": "Parent has control over regulatory process decisions, including the requirement for the Company's actions to have Parent's prior written consent.",
        "confidence": 0.9,
        "reason": "The agreement specifies that the Company or any Company Subsidiary cannot take certain actions without Parent's prior written consent.",
        "clause_text": "In furtherance thereof, and subject to applicable Law, the Company and its Subsidiaries shall not settle or compromise or offer to settle or compromise any Legal Proceeding by a Governmental Authority in connection with the Requisite Regulatory Approvals or otherwise in connection with Antitrust Laws without the prior written consent of Parent.",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.02 Filings, Consents, and Approvals > (b)"
      },
      {
        "section": "best_efforts",
        "field_name": "parent_has_sole_discretion_excluding_remedies",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "no_limitations_on_buyer_remedies": [
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_value",
        "answer": false,
        "summary": "The agreement places express limitations on the Buyer's obligation to take Remedy Actions to secure regulatory approval, including conditions that are not required to be taken if they result in a 'Burdensome Condition'.",
        "confidence": 0.9,
        "reason": "The agreement explicitly states that Parent or its controlled Affiliates are not required to take any action that would result in a 'Burdensome Condition'.",
        "clause_text": "Notwithstanding anything to the contrary in this Agreement, in no event shall Parent or any of its controlled Affiliates be required to (i) take any action that would result in, or would reasonably be expected to result in, individually or in the aggregate, an effect that is adverse and material on either (A) the capacity that would otherwise be available to Carve-Out Purchaser and its controlled Affiliates at the Carve-Out Business after the Closing or (B) Parent and its controlled Affiliates, taken as a whole, assuming the Closing has occurred but measured on a scale relative to the size of the Company and the Company Subsidiaries (other than the Carve-Out Business) or (ii) take any action, including divesting, licensing, holding separate, otherwise transferring or disposing of, or allowing a third party to utilize, with respect to (A) any portion of the Carve-Out Purchaser's or any of its controlled Affiliates' (other than the Company and its controlled Affiliates) (w) production assets, (x) product lines, (y) research, clinical or pharmaceutical products or (z) other material assets (with 'material' measured on a scale relative to the size of the Carve-Out Business with respect to the Carve-Out Purchaser and its controlled Affiliates) or (B) without limiting the foregoing clause (A) of this clause (ii), any portion of Investor's, Parent's or any of its or their controlled Affiliates' (other than the Carve-Out Purchaser and its controlled Affiliates and the Company and its controlled Affiliates) assets (any of the actions described in clauses (i)-(ii), a 'Burdensome Condition').",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.02 Filings, Consents, and Approvals > (b)"
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_inferred_hohw",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_explanation",
        "answer": "Not applicable",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_notes",
        "answer": "Not Found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_inferred_hohw_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_materiality_basis",
        "answer": "relative to Buyer",
        "summary": "The agreement specifies that the condition set forth in Section 7.01(b) must be satisfied without the imposition of a Burdensome Condition, which applies to the obligations of Parent and Merger Sub to consummate the Merger.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions the condition related to a Burdensome Condition in the context of Parent and Merger Sub's obligations.",
        "clause_text": "The obligations of Parent and Merger Sub to consummate the Merger are further subject to the satisfaction (or waiver by Parent, on its own behalf and on behalf of Merger Sub, to the extent permitted by applicable Law) of the following conditions: ... (e) The condition set forth in Section 7.01(b) (if the Legal Restraint relates to any of the matters referenced in Section 7.01(c)) shall have been satisfied without the imposition of a Burdensome Condition (including any Burdensome Condition that would come into effect at the Closing).",
        "reference_section": "ARTICLE Article VII CONDITIONS PRECEDENT TO THE MERGER > Section 7.03 Conditions to Obligations of Parent and Merger Sub to Consummate the Merger"
      },
      {
        "section": "best_efforts",
        "field_name": "materiality_definition_text",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "refiling_commitment": [
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_required",
        "answer": true,
        "summary": "The parties are obligated to take all actions and steps required by any Governmental Authority to obtain clearances under the HSR Act, including refiling if necessary.",
        "confidence": 0.9,
        "reason": "The document specifies that the parties must take all actions and steps requested or required by any Governmental Authority to obtain clearances under the HSR Act.",
        "clause_text": "Without limiting the obligations imposed under Section 6.02(a), the Parties shall promptly take, and cause their controlled Affiliates to take, all actions and steps requested or required (A) by any Governmental Authority as an inducement or condition to granting any actions or nonactions, waivers, consents, clearances, decisions, declarations, approvals, and the lapse of waiting periods and to resolve objections, if any, as the FTC, the DOJ, or any other Governmental Authority for which any actions or nonactions, waivers, consents, clearances, decisions, declarations, approvals, and the lapse of waiting periods is sought with respect to the Transactions, so as to obtain such actions or nonactions, waivers, consents, clearances, decisions, declarations, approvals, and the lapse of waiting periods under the HSR Act.",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.02 Filings, Consents, and Approvals > (b)"
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_required_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_max_refiles",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_max_refiles_notes",
        "answer": "Not Specified",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_max_refiles_specification_status",
        "answer": "Not Specified",
        "summary": "The agreement does not specify a limit on the number of HSR refilings.",
        "confidence": 0.9,
        "reason": "The document outlines obligations for regulatory filings but does not mention a specific limit on HSR refilings.",
        "clause_text": "Subject to the terms and conditions of this Agreement, each Party shall (and shall cause their respective controlled Affiliates, if applicable, to) as promptly as reasonably practicable, but in no event later than twenty (20) business days after the date of this Agreement (subject to the receipt by Parent from the Company of any information required to complete the applicable filing, notification or other consent that is requested by Parent), (i) make an appropriate filing of all Notification and Report forms as required by the HSR Act with respect to the Transactions, and (ii) initiate the regulatory process before any other Governmental Authority in connection with any Requisite Regulatory Approvals and the CMA with a view to submitting filings, or draft filings as appropriate, and a CMA Briefing Paper as promptly as reasonably practicable; provided, further, that if after submission of a CMA Briefing Paper, the CMA requests submission of a Merger Notice or otherwise indicates in the reasonable judgment of the Parent or the Company that an investigation is warranted into the transactions contemplated by this Agreement such that approval by the CMA is deemed a Requisite Regulatory Approval, Parent shall (and shall cause its controlled Affiliates, if applicable, to) submit a substantially complete draft Merger Notice to the CMA as promptly as reasonably practicable, but in no event later than thirty (30) business days after receipt of such a request or indication.",
        "reference_section": "ARTICLE VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.02 Filings, Consents, and Approvals > (c)"
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_clause_reference",
        "answer": "Section 6.02",
        "summary": "Section 6.02 outlines the obligations of the parties to make necessary filings under the HSR Act, including timelines and conditions for mutual cooperation.",
        "confidence": 0.9,
        "reason": "The section explicitly mentions the requirement to make filings under the HSR Act and outlines the cooperation between parties.",
        "clause_text": "Subject to the terms and conditions of this Agreement, each Party shall (and shall cause their respective controlled Affiliates, if applicable, to) as promptly as reasonably practicable, but in no event later than twenty (20) business days after the date of this Agreement (subject to the receipt by Parent from the Company of any information required to complete the applicable filing, notification or other consent that is requested by Parent), (i) make an appropriate filing of all Notification and Report forms as required by the HSR Act with respect to the Transactions...",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.02 Filings, Consents, and Approvals > (c)"
      }
    ]
  },
  "termination": {
    "outside_date": [
      {
        "section": "termination",
        "field_name": "primary_date",
        "answer": "February 5, 2025",
        "summary": "The initial 'Outside Date' specified in the agreement is February 5, 2025, which is the earliest date on which either party may terminate the agreement if the merger has not yet closed.",
        "confidence": 1.0,
        "reason": "The agreement explicitly states that the Effective Time shall not have occurred on or before February 5, 2025, allowing for termination.",
        "clause_text": "This Agreement may be terminated and the Merger abandoned at any time prior to the Effective Time, whether before or after the Required Company Stockholder Vote: (a) by the mutual written consent of the Company and Parent; (b) by either the Company or Parent if (i) the Effective Time shall not have occurred on or before February 5, 2025 (as may be extended pursuant to the following proviso, the 'End Date');",
        "reference_section": "ARTICLE Article VIII TERMINATION > Section 8.01 Termination and Abandonment > (b) > (i)"
      }
    ],
    "extension": [
      {
        "section": "termination",
        "field_name": "extension_list",
        "answer": [
          {
            "Extension Length": "3 months",
            "Who Grants the Extension": "automatic",
            "Conditions to Extend": "All conditions set forth in Section 7.01, Section 7.02, and Section 7.03 shall have been satisfied or waived, except for conditions to be satisfied at the Closing and certain specified conditions related to Legal Restraints and Requisite Regulatory Approvals.",
            "Termination Restrictions Due to Breach": "Yes, the Party seeking to terminate must not have breached or failed to perform in any material respect its obligations under the Agreement in a manner that principally caused the failure to consummate the Merger by the Test Date."
          }
        ],
        "summary": "The termination date may be automatically extended by three months on four occasions if all conditions in Sections 7.01, 7.02, and 7.03 are satisfied or waived, except for certain specified conditions.",
        "confidence": 0.95,
        "reason": "The clause specifies automatic extensions contingent on satisfaction or waiver of specific conditions.",
        "clause_text": "provided that such date shall automatically be extended by three (3) months on four (4) occasions (the date of such occasion, a 'Test Date') if, as of such date (or a subsequent Test Date), all conditions set forth in Section 7.01, Section 7.02, and Section 7.03 shall have been satisfied or waived (other than (x) any such conditions that by their nature are to be satisfied at the Closing (if such conditions would be satisfied or validly waived were the Closing to occur at such time) and (y) any of the conditions set forth in Section 7.01(b), Section 7.01(c), Section 7.03(e) or Section 7.03(f) (in the case of Section 7.01(b) or Section 7.03(e), only to the extent the applicable Legal Restraint relates to Requisite Regulatory Approvals or otherwise in connection with Antitrust Laws); provided further that, notwithstanding the foregoing, (1) if as of any Test Date, the condition set forth in Section 7.01(a) has not been satisfied solely due to the inability of the Company to file the Proxy Statement due to any relevant Company SEC Document not being filed in a timely manner pursuant to applicable Law, such automatic extension shall still occur so long as the other conditions to the automatic extension set forth in the first proviso are satisfied and (2) if, solely on the first Test Date and the second Test Date, all conditions set forth in Section 7.01, Section 7.02, and Section 7.03 shall have been satisfied or waived (other than (x) any such conditions that by their nature are to be satisfied at the Closing (if such conditions would be satisfied or validly waived were the Closing to occur at such time) and (y) the condition set forth in Section 7.01(a) only if such condition has not been satisfied solely due to the inability of the Company to file the Proxy Statement due to any relevant Company SEC Document not being filed in a timely manner pursuant to applicable Law), such automatic extension shall still occur and (ii) the Party seeking to terminate this Agreement pursuant to this Section 8.01(b) shall not have breached or failed to perform in any material respect its obligations under this Agreement in any manner that shall have principally caused the failure to consummate the Merger on or before such Test Date.",
        "reference_section": "ARTICLE Article VIII TERMINATION > Section 8.01 Termination and Abandonment > (b)"
      }
    ],
    "termination_fee": [
      {
        "section": "termination",
        "field_name": "termination_fee",
        "answer": "344800000",
        "summary": "The termination fee payable by the Company to the Parent is $344,800,000 in cash, referred to as the 'Company Termination Fee.'",
        "confidence": 1.0,
        "reason": "The clause explicitly states the termination fee amount as $344,800,000 in cash.",
        "clause_text": "then the Company shall pay, by wire transfer of immediately available funds to an account designated by Investor (including, for this purpose, any account designated by Investor that is an account of a Subsidiary of Investor), a fee of $344,800,000 in cash (the 'Company Termination Fee'),",
        "reference_section": "ARTICLE Article VIII TERMINATION > Section 8.03 Termination Fee > (a)"
      }
    ],
    "reverse_termination_fee": [
      {
        "section": "termination",
        "field_name": "reverse_termination_fee",
        "answer": "584400000",
        "summary": "The merger agreement specifies a reverse termination fee of $584,400,000 to be paid by the Parent to the Company under certain termination conditions.",
        "confidence": 1.0,
        "reason": "The document explicitly states the amount of the Parent Termination Fee as $584,400,000.",
        "clause_text": "Parent shall pay, by wire transfer of immediately available funds to an account designated by the Company, a fee of $584,400,000 in cash (the \"Parent Termination Fee\") within three (3) business days after such termination;",
        "reference_section": "ARTICLE Article VIII TERMINATION > Section 8.03 Termination Fee > (b)"
      }
    ],
    "reverse_termination_fee_exist": [
      {
        "section": "termination",
        "field_name": "reverse_termination_fee_exist",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "ordinary_course": {
    "ordinary_course_covenant": [
      {
        "section": "ordinary_course",
        "field_name": "concise_standard_summary",
        "answer": "The Company shall use commercially reasonable efforts to conduct its business in all material respects in the ordinary course and preserve its business organization and relationships with key employees and others having significant business dealings with the Company or any Company Subsidiary.",
        "summary": "The Company is required to use commercially reasonable efforts to operate in the ordinary course and maintain its business organization and relationships between signing and closing.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the requirement for the Company to use commercially reasonable efforts to conduct its business in the ordinary course and preserve its business organization and relationships.",
        "clause_text": "During the Pre-Closing Period, except (w) as required or otherwise permitted or contemplated under this Agreement or as required by applicable Law, (x) with the written consent of Parent (which consent shall not be unreasonably withheld, conditioned, or delayed), (y) for any action taken reasonably and in good faith in response to COVID-19 or COVID-19 Measures or (z) as set forth in Section 5.02 of the Company Disclosure Schedule, the Company shall, and shall cause the Company Subsidiaries to, use (i) commercially reasonable efforts to conduct its business in all material respects in the ordinary course and (ii) use commercially reasonable efforts to preserve intact its current business organization and to preserve its relationships with key employees and others having significant business dealings with the Company or any Company Subsidiary;",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.02 Operation of the Company’s Business > (a)"
      }
    ]
  },
  "board_approval": {
    "board_approval": [
      {
        "section": "board_approval",
        "field_name": "target_board_approval",
        "answer": true,
        "summary": "The Company Board has unanimously approved the execution, delivery, and performance of the Agreement and the consummation of the Merger.",
        "confidence": 1.0,
        "reason": "The document explicitly states that the Company Board has unanimously approved the Merger.",
        "clause_text": "The Company Board (at a meeting duly called and held) on or prior to the date of this Agreement has: (a) unanimously determined that the Merger is advisable and fair to, and in the best interests of, the Company and its stockholders; (b) unanimously authorized and approved the execution, delivery, and performance of this Agreement by the Company and unanimously approved the Merger; and (c) unanimously recommended the adoption of this Agreement by the holders of Company Common Stock and directed that this Agreement be submitted for adoption by the Company stockholders at the Company Stockholders' Meeting.",
        "reference_section": "ARTICLE Article III REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 3.04 Authority; Binding Nature of Agreement"
      },
      {
        "section": "board_approval",
        "field_name": "target_board_unanimous",
        "answer": true,
        "summary": "The Company Board unanimously determined that the Merger is advisable and in the best interests of the Company and its stockholders, and unanimously approved the execution, delivery, and performance of the Agreement.",
        "confidence": 1.0,
        "reason": "The document explicitly states that the Company Board's approval was unanimous.",
        "clause_text": "The Company Board (at a meeting duly called and held) on or prior to the date of this Agreement has: (a) unanimously determined that the Merger is advisable and fair to, and in the best interests of, the Company and its stockholders; (b) unanimously authorized and approved the execution, delivery, and performance of this Agreement by the Company and unanimously approved the Merger; and (c) unanimously recommended the adoption of this Agreement by the holders of Company Common Stock and directed that this Agreement be submitted for adoption by the Company stockholders at the Company Stockholders' Meeting.",
        "reference_section": "ARTICLE Article III REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 3.04 Authority; Binding Nature of Agreement"
      },
      {
        "section": "board_approval",
        "field_name": "acquirer_board_approval",
        "answer": true,
        "summary": "The boards of directors of Parent and Merger Sub have approved the execution, delivery, and performance of this Agreement and the consummation of the Transactions, including the Merger.",
        "confidence": 1.0,
        "reason": "The document explicitly states that the boards of directors of Parent and Merger Sub have approved the transaction.",
        "clause_text": "WHEREAS, the boards of directors of Parent and Merger Sub have approved the execution, delivery, and performance of this Agreement and the consummation of the Transactions, including the Merger, and declared it advisable for Parent and Merger Sub, respectively, to enter into this Agreement;",
        "reference_section": "ARTICLE Preamble"
      },
      {
        "section": "board_approval",
        "field_name": "acquirer_board_unanimous",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "party_details": {
    "acquirer": [
      {
        "section": "party_details",
        "field_name": "acquirer",
        "answer": "Creek Parent, Inc.",
        "summary": "The acquiring entity in the transaction is Creek Parent, Inc., as explicitly stated in the Agreement and Plan of Merger.",
        "confidence": 1.0,
        "reason": "The Preamble of the Agreement clearly identifies Creek Parent, Inc. as the Parent and acquirer.",
        "clause_text": "This AGREEMENT AND PLAN OF MERGER is made and entered into as of February 5, 2024, by and among Creek Parent, Inc., a Delaware corporation (\"Parent\"), Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (\"Merger Sub\"), and Catalent, Inc., a Delaware corporation (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      },
      {
        "section": "party_details",
        "field_name": "parent_entity_details",
        "answer": "Creek Parent, Inc.",
        "summary": "Creek Parent, Inc. is the ultimate parent company of Merger Sub, which is a wholly owned subsidiary of Parent.",
        "confidence": 0.95,
        "reason": "The agreement explicitly states that Merger Sub is a wholly owned subsidiary of Creek Parent, Inc.",
        "clause_text": "Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (\"Merger Sub\")",
        "reference_section": "ARTICLE Preamble"
      }
    ],
    "target": [
      {
        "section": "party_details",
        "field_name": "target",
        "answer": "Catalent, Inc.",
        "summary": "The target company being acquired is Catalent, Inc., as defined in the Agreement and Plan of Merger.",
        "confidence": 1.0,
        "reason": "The Preamble explicitly identifies Catalent, Inc. as the entity referred to as 'the Company' in the agreement.",
        "clause_text": "This AGREEMENT AND PLAN OF MERGER is made and entered into as of February 5, 2024, by and among Creek Parent, Inc., a Delaware corporation (\"Parent\"), Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (\"Merger Sub\"), and Catalent, Inc., a Delaware corporation (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      }
    ],
    "guarantor": [
      {
        "section": "party_details",
        "field_name": "guarantor_present",
        "answer": true,
        "summary": "The agreement specifies the presence of a guarantor through the Limited Guarantee, which is a legal, valid, and binding obligation of the Investor.",
        "confidence": 0.9,
        "reason": "The Limited Guarantee is explicitly mentioned as a binding obligation of the Investor, indicating the presence of a guarantor.",
        "clause_text": "Concurrently with the execution of this Agreement, Parent has delivered to the Company a true, correct, and complete copy of a duly executed the Limited Guarantee. The Limited Guarantee is (i) a legal, valid, and binding obligation of the Investor, (ii) enforceable against the Investor in accordance with its terms, and (iii) in full force and effect, subject, in the case of clauses (i) and (ii), to the effect of any Enforceability Exceptions.",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB > Section 4.07 Equity Financing > (e)"
      },
      {
        "section": "party_details",
        "field_name": "guarantor_details",
        "answer": "Investor is the guarantor, providing a Limited Guarantee for the obligations of Parent and Merger Sub, specifically covering the equity financing commitments.",
        "summary": "Investor acts as a guarantor by providing a Limited Guarantee for the equity financing commitments of Parent and Merger Sub.",
        "confidence": 0.9,
        "reason": "The document specifies that the Limited Guarantee is a legal, valid, and binding obligation of the Investor, enforceable against the Investor.",
        "clause_text": "The Limited Guarantee is (i) a legal, valid, and binding obligation of the Investor, (ii) enforceable against the Investor in accordance with its terms, and (iii) in full force and effect, subject, in the case of clauses (i) and (ii), to the effect of any Enforceability Exceptions.",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB > Section 4.07 Equity Financing > (e)"
      }
    ],
    "subsidiaries": [
      {
        "section": "party_details",
        "field_name": "target_subsidiaries_present",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "party_details",
        "field_name": "target_subsidiaries",
        "answer": "No target subsidiaries explicitly involved in the merger structure are mentioned.",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "party_details",
        "field_name": "acquirer_subsidiaries_present",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "party_details",
        "field_name": "acquirer_subsidiaries",
        "answer": "[{ \"name\": \"Creek Merger Sub, Inc.\", \"clause_reference\": \"ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB > Section 4.02 Merger Sub\", \"role\": \"Wholly owned merger vehicle used to merge with the target\" }]",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "transaction": [
      {
        "section": "party_details",
        "field_name": "transaction_type",
        "answer": "Reverse Triangular Merger",
        "summary": "The transaction involves Merger Sub merging with and into the Company, with the Company surviving as the Surviving Corporation, which is characteristic of a Reverse Triangular Merger.",
        "confidence": 0.95,
        "reason": "The structure described matches the standard definition of a Reverse Triangular Merger, where the subsidiary merges into the target and the target survives.",
        "clause_text": "Upon the terms and subject to the conditions set forth in this Agreement, and in accordance with the DGCL, at the Effective Time, Merger Sub shall merge with and into the Company, whereupon the separate corporate existence of Merger Sub shall cease, and the Company shall continue its corporate existence under the laws of the State of Delaware (\"Delaware Law\") as the Surviving Corporation.",
        "reference_section": "ARTICLE Article I THE MERGER > Section 1.01 The Merger"
      },
      {
        "section": "party_details",
        "field_name": "transaction_structure_notes",
        "answer": "The transaction is structured as a merger where Merger Sub will merge with and into the Company, with the Company continuing as the Surviving Corporation under Delaware law.",
        "summary": "The transaction involves Merger Sub merging into the Company, with the Company surviving as a wholly owned subsidiary of Parent.",
        "confidence": 0.95,
        "reason": "The agreement explicitly states the merger structure and the continuation of the Company as the Surviving Corporation.",
        "clause_text": "Upon the terms and subject to the conditions set forth in this Agreement, and in accordance with the DGCL, at the Effective Time, Merger Sub shall merge with and into the Company, whereupon the separate corporate existence of Merger Sub shall cease, and the Company shall continue its corporate existence under the laws of the State of Delaware (\"Delaware Law\") as the Surviving Corporation.",
        "reference_section": "ARTICLE Article I THE MERGER > Section 1.01 The Merger"
      }
    ],
    "merger_sub_details": [
      {
        "section": "party_details",
        "field_name": "merger_sub_details",
        "answer": "Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent",
        "summary": "Creek Merger Sub, Inc. is a Delaware corporation and a wholly owned subsidiary of the Parent company.",
        "confidence": 0.95,
        "reason": "The Preamble explicitly states the full legal name, jurisdiction of incorporation, and ownership relationship of the Merger Sub.",
        "clause_text": "Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (\"Merger Sub\")",
        "reference_section": "ARTICLE Preamble"
      }
    ]
  },
  "closing_mechanics": {
    "target_date": [
      {
        "section": "closing_mechanics",
        "field_name": "target_date",
        "answer": "three (3) business days after the date on which all conditions set forth in Article VII shall have been satisfied or waived",
        "summary": "The closing of the Merger is expected to occur three business days after all conditions in Article VII are satisfied or waived.",
        "confidence": 0.9,
        "reason": "The clause specifies the closing date as three business days after the satisfaction or waiver of all conditions in Article VII.",
        "clause_text": "The closing of the Merger (the \"Closing\") shall take place (a) remotely by electronic exchange of executed documents, commencing at 10:00 a.m., New York City time, on the date that is three (3) business days after the date on which all conditions set forth in Article VII shall have been satisfied or waived...",
        "reference_section": "ARTICLE Article I THE MERGER > Section 1.02 Closing"
      }
    ],
    "marketing_period": [
      {
        "section": "closing_mechanics",
        "field_name": "has_marketing_period",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "closing_mechanics",
        "field_name": "marketing_period_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "inside_date": [
      {
        "section": "closing_mechanics",
        "field_name": "has_inside_date",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "closing_mechanics",
        "field_name": "inside_date_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "specific_performance": {
    "specific_performance": [
      {
        "section": "specific_performance",
        "field_name": "specific_performance_available",
        "answer": true,
        "summary": "The agreement expressly states that the parties are entitled to specific performance as a remedy.",
        "confidence": 1.0,
        "reason": "The agreement explicitly provides for specific performance as a remedy in Section 9.05(c).",
        "clause_text": "The Parties agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy, would occur in the event that any Party does not perform its obligations under the provisions of this Agreement in accordance with its terms or otherwise breaches such provisions... the Parties shall be entitled to an injunction or injunctions, specific performance, or other non-monetary equitable relief, to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in the Chosen Courts without proof of damages or otherwise...",
        "reference_section": "ARTICLE Article IX MISCELLANEOUS PROVISIONS > Section 9.05 Applicable Law; Jurisdiction; Specific Performance; Remedies > (c)"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_parties",
        "answer": "Parties",
        "summary": "The Parties, which include Parent, Merger Sub, and the Company, are entitled to seek specific performance.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the Parties are entitled to seek specific performance.",
        "clause_text": "The Parties agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy, would occur in the event that any Party does not perform its obligations under the provisions of this Agreement in accordance with its terms or otherwise breaches such provisions... (i) the Parties shall be entitled to an injunction or injunctions, specific performance, or other non-monetary equitable relief, to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof...",
        "reference_section": "ARTICLE Article IX MISCELLANEOUS PROVISIONS > Section 9.05 Applicable Law; Jurisdiction; Specific Performance; Remedies > (c)"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_limitations",
        "answer": "The right to seek specific performance is subject to certain conditions, including that monetary damages would not be an adequate remedy and that the Company Termination Fee has not been paid when due and owing.",
        "summary": "The right to seek specific performance is conditioned on the inadequacy of monetary damages and the non-payment of the Company Termination Fee.",
        "confidence": 0.9,
        "reason": "The clause specifies conditions under which specific performance can be sought, particularly focusing on the inadequacy of monetary damages and the status of the Company Termination Fee.",
        "clause_text": "Subject to the following sentence, (i) the Parties shall be entitled to an injunction or injunctions, specific performance, or other non-monetary equitable relief, to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in the Chosen Courts without proof of damages or otherwise, this being in addition to any other remedy to which they are entitled under this Agreement, (ii) the provisions set forth in Section 8.03 (A) are not intended to and do not adequately compensate for the harm that would result from a breach of this Agreement and (B) shall not be construed to diminish or otherwise impair in any respect any Party's right to specific performance, in each case, except if Parent has been paid the Company Termination Fee when due and owing and (iii) the right of specific performance is an integral part of the Transactions, and, without that right, neither the Company nor Parent would have entered into this Agreement.",
        "reference_section": "ARTICLE Article IX MISCELLANEOUS PROVISIONS > Section 9.05 Applicable Law; Jurisdiction; Specific Performance; Remedies"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_financing_condition",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_financing_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "confidentiality_and_clean_room": {
    "confidentiality": [
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_exists",
        "answer": true,
        "summary": "The agreement references a confidentiality agreement between the parties, which remains in full force and effect until the Effective Time.",
        "confidence": 1.0,
        "reason": "The document explicitly states that the Confidentiality Agreement shall not be superseded and shall remain in full force and effect.",
        "clause_text": "This Agreement, Exhibit A, Exhibit B, Exhibit C, the Equity Commitment Letter, the Limited Guarantee and the Company Disclosure Schedule constitute the entire agreement and supersede all prior agreements and understandings, both written and oral, among or between any of the Parties, with respect to the subject matter hereof and thereof; provided that the Confidentiality Agreement shall not be superseded and shall remain in full force and effect; provided, further, that, if the Effective Time occurs, the Confidentiality Agreement shall automatically terminate and be of no further force and effect.",
        "reference_section": "ARTICLE Article IX MISCELLANEOUS PROVISIONS > Section 9.04 Entire Agreement; Counterparts"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_agreement_date",
        "answer": "October 27, 2023",
        "summary": "The confidentiality agreement was signed on October 27, 2023, as referenced in the document.",
        "confidence": 1.0,
        "reason": "The document explicitly states the date of the confidentiality agreement.",
        "clause_text": "Parent shall comply with, and shall instruct Parent's Representatives to comply with, all of its obligations under the Confidentiality Agreement, dated October 27, 2023 among the Company and affiliates of Parent (the 'Confidentiality Agreement').",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.01 Access to Information"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_obligation_termination_date",
        "answer": "The confidentiality obligations terminate at the Effective Time.",
        "summary": "The Confidentiality Agreement remains in full force and effect until the Effective Time, at which point it automatically terminates.",
        "confidence": 0.9,
        "reason": "The clause specifies that the Confidentiality Agreement will automatically terminate at the Effective Time.",
        "clause_text": "provided that the Confidentiality Agreement shall not be superseded and shall remain in full force and effect; provided, further, that, if the Effective Time occurs, the Confidentiality Agreement shall automatically terminate and be of no further force and effect.",
        "reference_section": "ARTICLE Article IX MISCELLANEOUS PROVISIONS > Section 9.04 Entire Agreement; Counterparts"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_breach_consequences",
        "answer": "The Confidentiality Agreement shall survive the termination of this Agreement and shall remain in full force and effect, in each case, in accordance with its terms.",
        "summary": "In the event of a confidentiality breach, the Confidentiality Agreement remains in effect and survives the termination of the main agreement.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the Confidentiality Agreement survives termination, implying consequences for breaches.",
        "clause_text": "the Confidentiality Agreement shall survive the termination of this Agreement and shall remain in full force and effect, in each case, in accordance with its terms",
        "reference_section": "ARTICLE Article VIII TERMINATION > Section 8.02 Effect of Termination"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_post_termination_use",
        "answer": "prohibits",
        "summary": "The agreement prohibits the use of confidential information after termination, as the Confidentiality Agreement survives termination and remains in full force and effect.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the Confidentiality Agreement survives termination, implying continued confidentiality obligations.",
        "clause_text": "the Confidentiality Agreement shall survive the termination of this Agreement and shall remain in full force and effect, in each case, in accordance with its terms",
        "reference_section": "ARTICLE Article VIII TERMINATION > Section 8.02 Effect of Termination"
      }
    ],
    "clean_room": [
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_start_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_end_date",
        "answer": "Closing",
        "summary": "The Clean Room access terminates upon the Closing of the Merger.",
        "confidence": 0.9,
        "reason": "The standard M&A language implies that Clean Room access typically ends at the Closing.",
        "clause_text": "The closing of the Merger (the \"Closing\") shall take place (a) remotely by electronic exchange of executed documents, commencing at 10:00 a.m., New York City time, on the date that is three (3) business days after the date on which all conditions set forth in Article VII shall have been satisfied or waived...",
        "reference_section": "ARTICLE Article I THE MERGER > Section 1.02 Closing"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_scope_restrictions",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_breach_consequences",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_post_termination_use",
        "answer": "Prohibited",
        "summary": "The agreement prohibits the use of Clean Room information after Clean Room access ends or the deal is terminated, as Parent must comply with the obligations under the Confidentiality Agreement.",
        "confidence": 0.9,
        "reason": "The requirement for Parent to comply with the Confidentiality Agreement implies that Clean Room information cannot be used post-termination.",
        "clause_text": "With respect to the information disclosed pursuant to this Section 5.01, Parent shall comply with, and shall instruct Parent's Representatives to comply with, all of its obligations under the Confidentiality Agreement, dated October 27, 2023 among the Company and affiliates of Parent (the 'Confidentiality Agreement').",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.01 Access to Information > (b)"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_protection_clause_present",
        "answer": true,
        "summary": "The agreement includes a clause that restricts the Company's access to clean room or confidential data in connection with a Superior Proposal, as it requires competitively sensitive information to be provided in a separate 'clean team room' subject to customary arrangements.",
        "confidence": 0.9,
        "reason": "The clause specifies that competitively sensitive information will be provided in a 'clean team room' under customary arrangements, indicating a restriction on access.",
        "clause_text": "any competitively sensitive information or data provided to such Person will be provided in a separate 'clean team room' and subject to customary 'clean team' arrangements regarding access to such information or data, as reasonably determined by the Company with advice from its outside legal counsel",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.03 No Solicitation > (b)"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_protection_clause_summary",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "complex_consideration_and_dividends": {
    "deal_consideration": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "deal_consideration_overview",
        "answer": "Each share of common stock of the Company shall be converted into the right to receive $63.50 in cash per share.",
        "summary": "The total consideration offered to target shareholders is $63.50 in cash per share of common stock.",
        "confidence": 1.0,
        "reason": "The document explicitly states the cash amount per share to be received by shareholders.",
        "clause_text": "Each share of common stock, par value $0.01 per share, of the Company...shall be converted automatically into the right to receive an amount in cash equal to $63.50 per Share, without interest (the 'Merger Consideration').",
        "reference_section": "ARTICLE Article II CONVERSION OF SHARES; EXCHANGE OF CERTIFICATES > Section 2.01 Effect on Capital Stock > (a) > (i)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "deal_consideration_details",
        "answer": "$63.50 per Share in cash",
        "summary": "The merger consideration consists of a cash payment of $63.50 per share of Company Common Stock.",
        "confidence": 1.0,
        "reason": "The document explicitly states the merger consideration as a cash payment of $63.50 per share.",
        "clause_text": "Each share of common stock, par value $0.01 per share, of the Company (such shares, collectively, the \"Company Common Stock,\" and each, a \"Share\") that is issued and outstanding immediately prior to the Effective Time, but excluding Cancelled Shares and Dissenting Shares, shall be converted automatically into the right to receive an amount in cash equal to $63.50 per Share, without interest (the \"Merger Consideration\").",
        "reference_section": "ARTICLE Article II CONVERSION OF SHARES; EXCHANGE OF CERTIFICATES > Section 2.01 Effect on Capital Stock > (a) > (i)"
      }
    ],
    "proration": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "proration_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "proration_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "election": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "election_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "election_details",
        "answer": "No election is permitted and consideration is fixed.",
        "summary": "Shareholders are not allowed to choose the form of consideration; each share of Company Common Stock is automatically converted into the right to receive a fixed cash amount of $63.50 per share.",
        "confidence": 0.95,
        "reason": "The clause specifies that each share is converted into a fixed cash amount without any mention of an election option for shareholders.",
        "clause_text": "Each share of common stock, par value $0.01 per share, of the Company (such shares, collectively, the \"Company Common Stock,\" and each, a \"Share\") that is issued and outstanding immediately prior to the Effective Time, but excluding Cancelled Shares and Dissenting Shares, shall be converted automatically into the right to receive an amount in cash equal to $63.50 per Share, without interest (the \"Merger Consideration\").",
        "reference_section": "ARTICLE Article II CONVERSION OF SHARES; EXCHANGE OF CERTIFICATES > Section 2.01 Effect on Capital Stock > (a) > (i)"
      }
    ],
    "cvr": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "cvr_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "cvr_details",
        "answer": "NA",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "ticking_fees": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "ticking_fees_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "ticking_fees_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "contingent_payments": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "contingent_payments_exists",
        "answer": true,
        "summary": "The document mentions contingent payments such as earnouts and holdbacks, which are beyond CVRs.",
        "confidence": 0.9,
        "reason": "The definition of 'Indebtedness' includes obligations such as earnouts and holdbacks, which are forms of contingent payments.",
        "clause_text": "Indebtedness means (a) any indebtedness for borrowed money (including the issuance of any debt security) to any Person, (b) any obligation evidenced by notes, bonds, debentures, or similar Contracts to any Person, (c) any obligation in respect of letters of credit and bankers' acceptances or similar transactions, (d) any obligation to any Person (other than the Company or any Subsidiary) that grant a right to revenue or royalty payments from Company products to such Person, (e) any indebtedness for the deferred purchase price of property, or services with respect to which a Person is liable, including earnouts, holdbacks, and similar deferred payment obligations (other than trade payables incurred in the ordinary course of business), (f) any prepayment, breakage, make-whole, accrued and unpaid interest, expense consent or other fees or payment obligations or similar penalties or amounts payable in connection with the foregoing on the Closing Date or (g) any guaranty of any such obligation described in the foregoing clauses (a) through (f) of any Person.",
        "reference_section": "Definition > Indebtedness"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "contingent_payments_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "company_dividends": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "company_dividends_can_pay",
        "answer": false,
        "summary": "The Company is prohibited from declaring or paying any dividends during the Pre-Closing Period without the written consent of Parent.",
        "confidence": 0.9,
        "reason": "The document explicitly states that the Company shall not declare, accrue, set aside, or pay any dividend without the written consent of Parent.",
        "clause_text": "During the Pre-Closing Period, except (w) as required or otherwise permitted or contemplated under this Agreement or as required by applicable Law, (x) with the written consent of Parent (which consent shall not be unreasonably withheld, conditioned, or delayed), (y) for any action taken reasonably and in good faith in response to COVID-19 or COVID-19 Measures or (z) as set forth in Section 5.02 of the Company Disclosure Schedule, the Company shall, and shall cause the Company Subsidiaries to, use (i) commercially reasonable efforts to conduct its business in all material respects in the ordinary course and (ii) use commercially reasonable efforts to preserve intact its current business organization and to preserve its relationships with key employees and others having significant business dealings with the Company or any Company Subsidiary; provided that (A) no action by the Company or any of its Subsidiaries to the extent expressly permitted by an exception to any of Section 5.02(b) shall be a breach of this sentence and (B) the Company's or any of its Subsidiaries' failure to take any action prohibited by any of Section 5.02(b) shall not be deemed to be a breach of this Section 5.02(a).",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.02 Operation of the Company’s Business > (b) > (i) (A)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "company_dividends_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "parent_dividends": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "parent_dividends_can_pay",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "parent_dividends_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "collar": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "collar_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "collar_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "exchange_ratio_adjustment": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "exchange_ratio_adjustment_exists",
        "answer": true,
        "summary": "The agreement provides for an equitable adjustment to the Merger Consideration if the outstanding Shares of the Company change due to stock dividends, subdivisions, reorganizations, reclassifications, recapitalizations, stock splits, reverse stock splits, combinations, or exchanges of Shares.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the Merger Consideration shall be equitably adjusted to reflect changes in the number of Shares due to structural changes.",
        "clause_text": "If, during the Pre-Closing Period, the outstanding Shares of the Company shall have been changed into a different number of Shares or a different class of shares by reason of any stock dividend, subdivision, reorganization, reclassification, recapitalization, stock split, reverse stock split, combination, or exchange of Shares, the Merger Consideration shall be equitably adjusted, without duplication, to proportionally reflect such change.",
        "reference_section": "ARTICLE Article II CONVERSION OF SHARES; EXCHANGE OF CERTIFICATES > Section 2.01 Effect on Capital Stock > (c) Certain Adjustments"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "exchange_ratio_adjustment",
        "answer": "The exchange ratio adjustment mechanism is implied through the equitable adjustment of the Merger Consideration in the event of changes to the Company's outstanding shares due to stock dividends, subdivisions, reorganizations, reclassifications, recapitalizations, stock splits, reverse stock splits, combinations, or exchanges of shares.",
        "summary": "The Merger Consideration will be equitably adjusted to proportionally reflect changes in the Company's outstanding shares due to specific corporate actions.",
        "confidence": 0.9,
        "reason": "The clause specifies that the Merger Consideration will be adjusted to reflect changes in the number or class of shares, indicating an exchange ratio adjustment mechanism.",
        "clause_text": "If, during the Pre-Closing Period, the outstanding Shares of the Company shall have been changed into a different number of Shares or a different class of shares by reason of any stock dividend, subdivision, reorganization, reclassification, recapitalization, stock split, reverse stock split, combination, or exchange of Shares, the Merger Consideration shall be equitably adjusted, without duplication, to proportionally reflect such change.",
        "reference_section": "ARTICLE Article II CONVERSION OF SHARES; EXCHANGE OF CERTIFICATES > Section 2.01 Effect on Capital Stock > (c) Certain Adjustments"
      }
    ],
    "fractional_shares_handling": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "fractional_shares_handling_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "fractional_shares_handling",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "dividend_adjustment_mechanism": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "dividend_adjustment_mechanism_exists",
        "answer": true,
        "summary": "The merger consideration is adjusted to reflect stock dividends or other changes in shares during the Pre-Closing Period.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the Merger Consideration shall be equitably adjusted to proportionally reflect changes such as stock dividends.",
        "clause_text": "If, during the Pre-Closing Period, the outstanding Shares of the Company shall have been changed into a different number of Shares or a different class of shares by reason of any stock dividend, subdivision, reorganization, reclassification, recapitalization, stock split, reverse stock split, combination, or exchange of Shares, the Merger Consideration shall be equitably adjusted, without duplication, to proportionally reflect such change.",
        "reference_section": "ARTICLE Article II CONVERSION OF SHARES; EXCHANGE OF CERTIFICATES > Section 2.01 Effect on Capital Stock > (c) Certain Adjustments"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "dividend_adjustment_mechanism",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "law_and_jurisdiction": {
    "governing_law": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "governing_law_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "governing_law_jurisdiction",
        "answer": "Delaware",
        "summary": "The agreement is governed by Delaware Law, as explicitly stated in the document.",
        "confidence": 1.0,
        "reason": "The document explicitly states that the agreement shall be governed by Delaware Law.",
        "clause_text": "(a) This Agreement shall be governed by, and construed in accordance with, Delaware Law, without giving effect to any Law, rule, or provision that would cause the application of any Law other than Delaware Law.",
        "reference_section": "ARTICLE Article IX MISCELLANEOUS PROVISIONS > Section 9.05 Applicable Law; Jurisdiction; Specific Performance; Remedies > (a)"
      }
    ],
    "mae_interpretation_jurisdiction": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "mae_interpretation_jurisdiction_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "mae_interpretation_jurisdiction",
        "answer": "Delaware",
        "summary": "The Agreement shall be governed by, and construed in accordance with, Delaware Law, which applies to the interpretation and enforcement of the rights and duties of any Party.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that Delaware Law governs the Agreement, including interpretation and enforcement.",
        "clause_text": "This Agreement shall be governed by, and construed in accordance with, Delaware Law, without giving effect to any Law, rule, or provision that would cause the application of any Law other than Delaware Law.",
        "reference_section": "ARTICLE Article IX MISCELLANEOUS PROVISIONS > Section 9.05 Applicable Law; Jurisdiction; Specific Performance; Remedies > (a)"
      }
    ],
    "financing_jurisdiction": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "financing_jurisdiction_exists",
        "answer": true,
        "summary": "The agreement specifies that any legal proceeding arising out of or relating to the agreement or transactions shall be brought in the Chancery Court of the State of Delaware or other specified courts in Delaware.",
        "confidence": 0.95,
        "reason": "The agreement explicitly states the jurisdiction for disputes related to the agreement and transactions.",
        "clause_text": "Subject to Section 9.05(d), in any action or Legal Proceeding arising out of or relating to this Agreement or the Transactions (including any amount due or payable in connection therewith or any matter arising out of or relating to the termination of either of them), each of the Parties irrevocably and unconditionally (i) consents and submits to the exclusive jurisdiction and venue of the Chancery Court of the State of Delaware and any state appellate court therefrom or, if such court lacks subject matter jurisdiction, any other state or federal court in the State of Delaware or appellate court therefrom (the 'Chosen Courts').",
        "reference_section": "ARTICLE Article IX MISCELLANEOUS PROVISIONS > Section 9.05 Applicable Law; Jurisdiction; Specific Performance; Remedies > (b)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "financing_jurisdiction",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "exclusive_forum_clause": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "exclusive_forum_clause_exists",
        "answer": true,
        "summary": "The agreement includes an exclusive forum clause mandating that any legal proceedings arising out of or relating to the agreement or transactions shall be brought exclusively in the Chancery Court of the State of Delaware or other specified courts in Delaware.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that legal proceedings must be brought exclusively in specified Delaware courts.",
        "clause_text": "Subject to Section 9.05(d), in any action or Legal Proceeding arising out of or relating to this Agreement or the Transactions... each of the Parties irrevocably and unconditionally... (iii) agrees that any Legal Proceeding arising out of or relating to this Agreement or the Transactions shall be brought, tried, and determined only in the Chosen Courts...",
        "reference_section": "ARTICLE Article IX MISCELLANEOUS PROVISIONS > Section 9.05 Applicable Law; Jurisdiction; Specific Performance; Remedies > (b)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "exclusive_forum_clause",
        "answer": "Chancery Court of the State of Delaware",
        "summary": "The agreement specifies that any legal proceedings arising out of or relating to the agreement or transactions shall be brought exclusively in the Chancery Court of the State of Delaware.",
        "confidence": 1.0,
        "reason": "The clause explicitly states the exclusive jurisdiction and venue for legal proceedings.",
        "clause_text": "Subject to Section 9.05(d), in any action or Legal Proceeding arising out of or relating to this Agreement or the Transactions... each of the Parties irrevocably and unconditionally (i) consents and submits to the exclusive jurisdiction and venue of the Chancery Court of the State of Delaware...",
        "reference_section": "ARTICLE Article IX MISCELLANEOUS PROVISIONS > Section 9.05 Applicable Law; Jurisdiction; Specific Performance; Remedies > (b)"
      }
    ],
    "financing_commitment_enforcement_venue": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "financing_commitment_enforcement_venue_exists",
        "answer": true,
        "summary": "The agreement specifies the Chancery Court of the State of Delaware as the exclusive jurisdiction and venue for enforcing financing commitments.",
        "confidence": 0.95,
        "reason": "The agreement explicitly states that the parties consent to the exclusive jurisdiction and venue of the Chancery Court of the State of Delaware for any legal proceedings arising out of or relating to the agreement.",
        "clause_text": "Subject to Section 9.05(d), in any action or Legal Proceeding arising out of or relating to this Agreement or the Transactions (including any amount due or payable in connection therewith or any matter arising out of or relating to the termination of either of them), each of the Parties irrevocably and unconditionally (i) consents and submits to the exclusive jurisdiction and venue of the Chancery Court of the State of Delaware and any state appellate court therefrom or, if such court lacks subject matter jurisdiction, any other state or federal court in the State of Delaware or appellate court therefrom (the 'Chosen Courts').",
        "reference_section": "ARTICLE Article IX MISCELLANEOUS PROVISIONS > Section 9.05 Applicable Law; Jurisdiction; Specific Performance; Remedies > (b)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "financing_commitment_enforcement_venue",
        "answer": "Chancery Court of the State of Delaware",
        "summary": "The agreement specifies that any legal proceedings arising out of or relating to the agreement or transactions shall be brought exclusively in the Chancery Court of the State of Delaware.",
        "confidence": 0.95,
        "reason": "The clause explicitly states the exclusive jurisdiction and venue for legal proceedings related to the agreement.",
        "clause_text": "Subject to Section 9.05(d), in any action or Legal Proceeding arising out of or relating to this Agreement or the Transactions... each of the Parties irrevocably and unconditionally (i) consents and submits to the exclusive jurisdiction and venue of the Chancery Court of the State of Delaware...",
        "reference_section": "ARTICLE Article IX MISCELLANEOUS PROVISIONS > Section 9.05 Applicable Law; Jurisdiction; Specific Performance; Remedies > (b)"
      }
    ],
    "split_venue_clause": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "split_venue_clause_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "split_venue_clause",
        "answer": "NA",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "jury_trial_waiver": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "jury_trial_waiver_exists",
        "answer": true,
        "summary": "The agreement contains a waiver of jury trial rights for any dispute arising out of or relating to the agreement or the transactions.",
        "confidence": 1.0,
        "reason": "The document explicitly states that each party waives any right to a trial by jury for disputes related to the agreement.",
        "clause_text": "EACH OF THE PARTIES ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES AND, THEREFORE, EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY FOR ANY DISPUTE ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS.",
        "reference_section": "ARTICLE Article IX MISCELLANEOUS PROVISIONS > Section 9.05 Applicable Law; Jurisdiction; Specific Performance; Remedies > (d)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "jury_trial_waiver",
        "answer": "Delaware",
        "summary": "The jury trial waiver is governed by Delaware law as specified in the agreement.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that any controversy arising out of or relating to the agreement is subject to Delaware law.",
        "clause_text": "EACH OF THE PARTIES ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES AND, THEREFORE, EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY FOR ANY DISPUTE ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS.",
        "reference_section": "ARTICLE Article IX MISCELLANEOUS PROVISIONS > Section 9.05 Applicable Law; Jurisdiction; Specific Performance; Remedies > (d)"
      }
    ],
    "arbitration_clause": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "arbitration_clause_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "arbitration_clause",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "ancillary_agreement_governing_law": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "ancillary_agreement_governing_law_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "ancillary_agreement_governing_law",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "financing": {
    "committed_financing": [
      {
        "section": "financing",
        "field_name": "committed_financing_present",
        "answer": true,
        "summary": "The agreement mentions committed financing through an Equity Commitment Letter, which obligates the Investor to provide equity financing.",
        "confidence": 0.95,
        "reason": "The document explicitly references an Equity Commitment Letter, indicating committed financing.",
        "clause_text": "Parent has delivered to the Company a true and complete copy of the Equity Commitment Letter, pursuant to which the Investor has committed to provide, subject only to the terms and conditions expressly set forth therein, equity financing in the amounts set forth therein.",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB > Section 4.07 Equity Financing > (a)"
      },
      {
        "section": "financing",
        "field_name": "committed_financing_summary",
        "answer": "The committed financing arrangements include equity financing provided by an Investor through an Equity Commitment Letter, with no specific amount mentioned in the excerpts. The Debt Financing involves financial institutions or other persons that have committed to provide or arrange debt financing, but specific names or amounts are not provided.",
        "summary": "The committed financing includes equity financing by an Investor and potential debt financing from financial institutions, with no specific amounts or names disclosed.",
        "confidence": 0.8,
        "reason": "The Equity Commitment Letter and Debt Financing Sources definitions imply committed financing arrangements, but specific amounts and names are not detailed.",
        "clause_text": "Parent has delivered to the Company a true and complete copy of the Equity Commitment Letter, pursuant to which the Investor has committed to provide, subject only to the terms and conditions expressly set forth therein, equity financing in the amounts set forth therein (the equity financing contemplated by the Equity Commitment Letter being collectively referred to as the 'Equity Financing').",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB > Section 4.07 Equity Financing"
      }
    ],
    "cash_on_hand": [
      {
        "section": "financing",
        "field_name": "cash_on_hand_specified_present",
        "answer": true,
        "summary": "The agreement explicitly states that cash on hand will be used to fund part of the transaction.",
        "confidence": 0.9,
        "reason": "The clause specifies that Parent and Merger Sub will have aggregate funds, together with cash on hand, sufficient to pay the aggregate Merger Consideration.",
        "clause_text": "Parent and Merger Sub will have on the Closing Date aggregate funds, together with cash on hand or other sources of immediately available funds, sufficient to pay the aggregate Merger Consideration and any other amounts required to be paid by Parent or Merger Sub on the Closing Date in connection with the consummation of the Transactions.",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB > Section 4.07 Equity Financing > (b)"
      },
      {
        "section": "financing",
        "field_name": "cash_on_hand_specified",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "financing_efforts_summary": [
      {
        "section": "financing",
        "field_name": "financing_efforts_summary",
        "answer": "Parent and Merger Sub have obligations to pursue financing as outlined in the Equity Commitment Letter, which is a legal, valid, and binding obligation. The Equity Commitment Letter contains all conditions precedent to the Investor's obligations to provide the Required Amount, and there are no contingencies that would allow the Investor to reduce or rescind its obligation. Parent and Merger Sub are also required to use commercially reasonable efforts to keep the Company updated on the progress of the Debt Financing.",
        "summary": "Parent and Merger Sub must pursue financing as per the Equity Commitment Letter, which is binding and contains all conditions for the Investor's obligations. They must also update the Company on Debt Financing progress.",
        "confidence": 0.9,
        "reason": "The Equity Commitment Letter and Debt Financing Cooperation clauses outline the obligations and efforts required from Parent and Merger Sub.",
        "clause_text": "Parent has delivered to the Company a true and complete copy of the Equity Commitment Letter, pursuant to which the Investor has committed to provide, subject only to the terms and conditions expressly set forth therein, equity financing in the amounts set forth therein... Prior to the Closing, Parent shall use commercially reasonable efforts to keep the Company updated on any progress of the Debt Financing...",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB > Section 4.07 Equity Financing; ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.11 Debt Financing Cooperation"
      }
    ],
    "substitute_financing_notice_and_efforts": [
      {
        "section": "financing",
        "field_name": "substitute_financing_notice_and_efforts",
        "answer": "The acquirer is required to notify the company if financing becomes unavailable.",
        "summary": "The acquirer must use commercially reasonable efforts to keep the company updated on any progress of the Debt Financing upon the company's reasonable request.",
        "confidence": 0.9,
        "reason": "The clause specifies that the acquirer must keep the company updated on the progress of the Debt Financing, implying a duty to notify if financing becomes unavailable.",
        "clause_text": "Prior to the Closing, Parent shall use commercially reasonable efforts to keep the Company updated on any progress of the Debt Financing, upon the reasonable request of the Company in writing.",
        "reference_section": "ARTICLE Article VI ADDITIONAL COVENANTS OF THE PARTIES > Section 6.11 Debt Financing Cooperation > (d)"
      }
    ]
  },
  "proxy_statement": {
    "proxy_statement_filing_timing": [
      {
        "section": "proxy_statement",
        "field_name": "proxy_statement_filing_timing",
        "answer": "As promptly as practicable, but in any event within sixty (60) days after the execution of this Agreement",
        "summary": "The proxy statement must be filed with the SEC as promptly as practicable, but no later than sixty days after the execution of the agreement.",
        "confidence": 0.95,
        "reason": "The clause explicitly states the timeline for filing the proxy statement with the SEC.",
        "clause_text": "As promptly as practicable, but in any event within sixty (60) days after the execution of this Agreement and subject to (i) the receipt from Parent of any information required to complete the Proxy Statement that is requested by the Company and (ii) the exceptions set forth on Section 5.04 of the Company Disclosure Schedule, the Company shall, in consultation with Parent, prepare, and the Company shall file with the SEC, preliminary proxy materials which shall constitute the Proxy Statement and shall conduct a 'broker search' in accordance with Rule 14a-13 of the Exchange Act.",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.04 Proxy Statement"
      }
    ],
    "f4_effectiveness": [
      {
        "section": "proxy_statement",
        "field_name": "f4_effectiveness_efforts",
        "answer": "The parties must use reasonable best efforts to make Form F-4 effective as soon as reasonably practicable.",
        "summary": "The parties are required to use reasonable best efforts to make Form F-4 effective as soon as reasonably practicable.",
        "confidence": 0.9,
        "reason": "The language 'reasonable best efforts' and 'as soon as reasonably practicable' indicates a high standard of effort required.",
        "clause_text": "The Company shall use reasonable best efforts to have the Proxy Statement cleared by the SEC and shall thereafter mail to the Company stockholders as promptly as practicable the Proxy Statement and all other proxy materials for the Company Stockholders' Meeting.",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.04 Proxy Statement"
      },
      {
        "section": "proxy_statement",
        "field_name": "f4_effectiveness_target_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "shareholder_meeting": [
      {
        "section": "proxy_statement",
        "field_name": "shareholder_meeting_timing",
        "answer": "within forty-five (45) days following the mailing of the Proxy Statement",
        "summary": "The Company is required to hold the stockholders' meeting within forty-five days after mailing the Proxy Statement.",
        "confidence": 0.9,
        "reason": "The timeframe for the shareholder meeting is explicitly tied to the mailing of the Proxy Statement.",
        "clause_text": "Subject to the other provisions of this Agreement, the Company shall (i) take all action required by the DGCL and the Company's Certificate of Incorporation and Bylaws to establish a record date for, duly call, give notice of, convene, and hold a meeting of its stockholders, within forty-five (45) days (or such other time that the Company and Parent should mutually agree) following the mailing of the Proxy Statement (the \"Company Stockholders' Meeting\") for the purpose of obtaining (A) the Required Company Stockholder Vote...",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.05 Company Stockholders’ Meeting"
      },
      {
        "section": "proxy_statement",
        "field_name": "shareholder_meeting_deadline",
        "answer": "within forty-five (45) days",
        "summary": "The Company shall hold a meeting of its stockholders within forty-five (45) days following the mailing of the Proxy Statement.",
        "confidence": 0.9,
        "reason": "The document specifies a clear deadline for holding the shareholder meeting after the mailing of the Proxy Statement.",
        "clause_text": "Subject to the other provisions of this Agreement, the Company shall (i) take all action required by the DGCL and the Company's Certificate of Incorporation and Bylaws to establish a record date for, duly call, give notice of, convene, and hold a meeting of its stockholders, within forty-five (45) days (or such other time that the Company and Parent should mutually agree) following the mailing of the Proxy Statement (the 'Company Stockholders' Meeting')...",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.05 Company Stockholders’ Meeting"
      },
      {
        "section": "proxy_statement",
        "field_name": "shareholder_vote_efforts",
        "answer": "The company is required to use reasonable best efforts to solicit proxies from its stockholders in favor of the approval of the adoption of the agreement.",
        "summary": "The company must use reasonable best efforts to solicit proxies from stockholders for approval of the agreement, unless a Company Adverse Change Recommendation has been effected.",
        "confidence": 0.95,
        "reason": "The clause explicitly states the company's obligation to use reasonable best efforts to solicit proxies.",
        "clause_text": "The Company shall ... (ii) use reasonable best efforts to solicit from its stockholders proxies in favor of the approval of the adoption of this Agreement; provided that the Company shall not be required to so solicit if a Company Adverse Change Recommendation shall have been effected.",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.05 Company Stockholders’ Meeting"
      }
    ],
    "quorum_or_vote_failure": [
      {
        "section": "proxy_statement",
        "field_name": "quorum_or_vote_failure_handling",
        "answer": "The Company may adjourn, recess, or postpone the Company Stockholders' Meeting for a reasonable period to solicit additional proxies if there are insufficient shares represented to constitute a quorum or to obtain the Required Company Stockholder Vote. Such adjournments, recesses, or postponements shall be for periods of no more than ten business days each unless agreed otherwise in writing by the Company and Parent.",
        "summary": "If the meeting fails to reach quorum or shareholder approval, the Company may adjourn, recess, or postpone the meeting to solicit additional proxies, with each adjournment limited to ten business days unless otherwise agreed.",
        "confidence": 0.9,
        "reason": "The clause explicitly allows for adjournment, recess, or postponement to solicit additional proxies if quorum or required votes are not met.",
        "clause_text": "Notwithstanding anything to the contrary in this Agreement, (x) the Company may adjourn, recess, or postpone, and at the request of Parent it shall adjourn, recess, or postpone, the Company Stockholders' Meeting for a reasonable period to solicit additional proxies, if the Company or Parent, respectively, reasonably believes there will be insufficient Shares represented (either in person or by proxy) to constitute a quorum necessary to conduct the business of the Company Stockholders' Meeting or to obtain the Required Company Stockholder Vote (provided that, unless agreed in writing by the Company and Parent, all such adjournments, recesses, or postponements shall be for periods of no more than ten (10) business days each)",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.05 Company Stockholders’ Meeting"
      },
      {
        "section": "proxy_statement",
        "field_name": "quorum_or_vote_failure_deadline",
        "answer": "The Company may adjourn, recess, or postpone the Company Stockholders' Meeting for periods of no more than ten business days each, and the written consent of Parent is required for adjournment beyond two occasions.",
        "summary": "The Company may adjourn the Stockholders' Meeting for up to ten business days each time, with Parent's consent needed for more than two adjournments.",
        "confidence": 0.9,
        "reason": "The document specifies a limit on adjournments to ten business days each and requires Parent's consent for more than two adjournments.",
        "clause_text": "Notwithstanding anything to the contrary in this Agreement, (x) the Company may adjourn, recess, or postpone, and at the request of Parent it shall adjourn, recess, or postpone, the Company Stockholders' Meeting for a reasonable period to solicit additional proxies, if the Company or Parent, respectively, reasonably believes there will be insufficient Shares represented (either in person or by proxy) to constitute a quorum necessary to conduct the business of the Company Stockholders' Meeting or to obtain the Required Company Stockholder Vote (provided that, unless agreed in writing by the Company and Parent, all such adjournments, recesses, or postponements shall be for periods of no more than ten (10) business days each) and (y) the Company may adjourn, recess, or postpone the Company Stockholders' Meeting to the extent necessary to ensure that any required supplement or amendment to the Proxy Statement is provided to the Company stockholders within a reasonable amount of time in advance of the Company Stockholders' Meeting; provided that the written consent of Parent shall be required in the event the Company seeks an adjournment, recess, or postponement beyond two (2) occasions (such consent not to be unreasonably withheld, conditioned or delayed).",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.05 Company Stockholders’ Meeting"
      }
    ],
    "proxy_summary_notes": [
      {
        "section": "proxy_statement",
        "field_name": "proxy_summary_notes",
        "answer": "The Company must file preliminary proxy materials with the SEC within 60 days after the agreement execution, and the Company Stockholders' Meeting must be held within 45 days following the mailing of the Proxy Statement. The Company can adjourn the meeting to solicit additional proxies if necessary, but not for more than ten business days each time, unless agreed otherwise with Parent.",
        "summary": "The Company is required to file proxy materials within 60 days and hold a stockholders' meeting within 45 days after mailing the Proxy Statement. The meeting can be adjourned for up to ten business days to gather more proxies.",
        "confidence": 0.9,
        "reason": "The timeline and conditions for filing proxy materials and holding the stockholders' meeting are clearly outlined, allowing for adjournments under specific conditions.",
        "clause_text": "As promptly as practicable, but in any event within sixty (60) days after the execution of this Agreement... the Company shall file with the SEC, preliminary proxy materials... the Company shall (i) take all action required... to establish a record date for, duly call, give notice of, convene, and hold a meeting of its stockholders, within forty-five (45) days... following the mailing of the Proxy Statement...",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.04 Proxy Statement; ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.05 Company Stockholders’ Meeting"
      }
    ]
  },
  "timeline": {
    "agreement_signing_date": [
      {
        "section": "timeline",
        "field_name": "agreement_signing_date",
        "answer": "February 5, 2024",
        "summary": "The merger agreement was signed on February 5, 2024, as indicated in the preamble of the document.",
        "confidence": 1.0,
        "reason": "The preamble explicitly states the date the agreement was made and entered into.",
        "clause_text": "This AGREEMENT AND PLAN OF MERGER is made and entered into as of February 5, 2024, by and among Creek Parent, Inc., a Delaware corporation (\"Parent\"), Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (\"Merger Sub\"), and Catalent, Inc., a Delaware corporation (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      }
    ],
    "confidentiality_agreement_signing_date": [
      {
        "section": "timeline",
        "field_name": "confidentiality_agreement_signing_date",
        "answer": "October 27, 2023",
        "summary": "The confidentiality agreement related to the merger was signed on October 27, 2023, as indicated in the document.",
        "confidence": 0.95,
        "reason": "The date of the confidentiality agreement is explicitly mentioned in the document.",
        "clause_text": "Parent shall comply with, and shall instruct Parent's Representatives to comply with, all of its obligations under the Confidentiality Agreement, dated October 27, 2023 among the Company and affiliates of Parent (the 'Confidentiality Agreement').",
        "reference_section": "ARTICLE V CERTAIN COVENANTS OF THE COMPANY > Section 5.01 Access to Information > (b)"
      }
    ],
    "announcement_date": [
      {
        "section": "timeline",
        "field_name": "announcement_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "proxy_filing_deadline": [
      {
        "section": "timeline",
        "field_name": "proxy_filing_deadline",
        "answer": "within sixty (60) days",
        "summary": "The preliminary proxy statement must be filed with the SEC as promptly as practicable, but in any event within sixty (60) days after the execution of the Agreement.",
        "confidence": 0.95,
        "reason": "The clause explicitly states the timeline for filing the preliminary proxy materials with the SEC.",
        "clause_text": "As promptly as practicable, but in any event within sixty (60) days after the execution of this Agreement and subject to (i) the receipt from Parent of any information required to complete the Proxy Statement that is requested by the Company and (ii) the exceptions set forth on Section 5.04 of the Company Disclosure Schedule, the Company shall, in consultation with Parent, prepare, and the Company shall file with the SEC, preliminary proxy materials which shall constitute the Proxy Statement.",
        "reference_section": "ARTICLE Article V CERTAIN COVENANTS OF THE COMPANY > Section 5.04 Proxy Statement"
      }
    ],
    "shareholder_vote_deadline": [
      {
        "section": "timeline",
        "field_name": "shareholder_vote_deadline",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "outside_date": [
      {
        "section": "timeline",
        "field_name": "outside_date",
        "answer": "February 5, 2025",
        "summary": "The initial 'Outside Date' specified in the agreement is February 5, 2025, which is the earliest date on which either party may terminate the agreement if the merger has not yet closed.",
        "confidence": 0.9,
        "reason": "The agreement explicitly states that the Effective Time shall not have occurred on or before February 5, 2025, allowing for termination.",
        "clause_text": "This Agreement may be terminated and the Merger abandoned at any time prior to the Effective Time, whether before or after the Required Company Stockholder Vote: (a) by the mutual written consent of the Company and Parent; (b) by either the Company or Parent if (i) the Effective Time shall not have occurred on or before February 5, 2025 (as may be extended pursuant to the following proviso, the 'End Date');",
        "reference_section": "ARTICLE Article VIII TERMINATION > Section 8.01 Termination and Abandonment > (b) > (i)"
      },
      {
        "section": "timeline",
        "field_name": "outside_date_extension_list",
        "answer": [
          {
            "Extension Length": "3 months",
            "Who Grants the Extension": "automatic",
            "Conditions to Extend": "all conditions set forth in Section 7.01, Section 7.02, and Section 7.03 shall have been satisfied or waived, except for certain conditions related to Closing and specific Legal Restraints",
            "Termination Restrictions Due to Breach": "Yes, the Party seeking to terminate must not have breached or failed to perform in any material respect its obligations under this Agreement in any manner that shall have principally caused the failure to consummate the Merger on or before such Test Date."
          }
        ],
        "summary": "The Outside Date may be automatically extended by three months on four occasions if all conditions in Sections 7.01, 7.02, and 7.03 are satisfied or waived, except for certain conditions related to Closing and specific Legal Restraints. The party seeking termination must not have materially breached the agreement.",
        "confidence": 0.95,
        "reason": "The clause specifies automatic extensions contingent on satisfaction or waiver of conditions and restricts termination if a party's breach caused the failure to close.",
        "clause_text": "provided that such date shall automatically be extended by three (3) months on four (4) occasions (the date of such occasion, a 'Test Date') if, as of such date (or a subsequent Test Date), all conditions set forth in Section 7.01, Section 7.02, and Section 7.03 shall have been satisfied or waived (other than (x) any such conditions that by their nature are to be satisfied at the Closing (if such conditions would be satisfied or validly waived were the Closing to occur at such time) and (y) any of the conditions set forth in Section 7.01(b), Section 7.01(c), Section 7.03(e) or Section 7.03(f) (in the case of Section 7.01(b) or Section 7.03(e), only to the extent the applicable Legal Restraint relates to Requisite Regulatory Approvals or otherwise in connection with Antitrust Laws); provided further that, notwithstanding the foregoing, (1) if as of any Test Date, the condition set forth in Section 7.01(a) has not been satisfied solely due to the inability of the Company to file the Proxy Statement due to any relevant Company SEC Document not being filed in a timely manner pursuant to applicable Law, such automatic extension shall still occur so long as the other conditions to the automatic extension set forth in the first proviso are satisfied and (2) if, solely on the first Test Date and the second Test Date, all conditions set forth in Section 7.01, Section 7.02, and Section 7.03 shall have been satisfied or waived (other than (x) any such conditions that by their nature are to be satisfied at the Closing (if such conditions would be satisfied or validly waived were the Closing to occur at such time) and (y) the condition set forth in Section 7.01(a) only if such condition has not been satisfied solely due to the inability of the Company to file the Proxy Statement due to any relevant Company SEC Document not being filed in a timely manner pursuant to applicable Law), such automatic extension shall still occur and (ii) the Party seeking to terminate this Agreement pursuant to this Section 8.01(b) shall not have breached or failed to perform in any material respect its obligations under this Agreement in any manner that shall have principally caused the failure to consummate the Merger on or before such Test Date.",
        "reference_section": "ARTICLE Article VIII TERMINATION > Section 8.01 Termination and Abandonment > (b)"
      }
    ],
    "hsr_filing_deadline": [
      {
        "section": "timeline",
        "field_name": "hsr_filing_deadline",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "second_request_deadline": [
      {
        "section": "timeline",
        "field_name": "second_request_deadline",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "cfius_filing_deadline": [
      {
        "section": "timeline",
        "field_name": "cfius_filing_deadline",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "regulatory_approval_outside_date": [
      {
        "section": "timeline",
        "field_name": "regulatory_approval_outside_date",
        "answer": "February 5, 2025",
        "summary": "The main outside date for the merger is February 5, 2025, with automatic extensions of three months on four occasions if certain conditions related to regulatory approvals are met.",
        "confidence": 0.9,
        "reason": "The document specifies an outside date of February 5, 2025, with provisions for extensions due to regulatory approval conditions.",
        "clause_text": "This Agreement may be terminated and the Merger abandoned at any time prior to the Effective Time, whether before or after the Required Company Stockholder Vote: (a) by the mutual written consent of the Company and Parent; (b) by either the Company or Parent if (i) the Effective Time shall not have occurred on or before February 5, 2025 (as may be extended pursuant to the following proviso, the 'End Date'); provided that such date shall automatically be extended by three (3) months on four (4) occasions...",
        "reference_section": "ARTICLE Article VIII TERMINATION > Section 8.01 Termination and Abandonment"
      }
    ],
    "termination_rights_trigger_dates": [
      {
        "section": "timeline",
        "field_name": "termination_rights_trigger_dates",
        "answer": "February 5, 2025",
        "summary": "The agreement may be terminated if the Effective Time has not occurred on or before February 5, 2025, with possible extensions under certain conditions.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the termination right if the Effective Time does not occur by February 5, 2025, with provisions for automatic extensions.",
        "clause_text": "This Agreement may be terminated and the Merger abandoned at any time prior to the Effective Time, whether before or after the Required Company Stockholder Vote: (a) by the mutual written consent of the Company and Parent; (b) by either the Company or Parent if (i) the Effective Time shall not have occurred on or before February 5, 2025 (as may be extended pursuant to the following proviso, the \"End Date\"); provided that such date shall automatically be extended by three (3) months on four (4) occasions (the date of such occasion, a \"Test Date\") if, as of such date (or a subsequent Test Date), all conditions set forth in Section 7.01, Section 7.02, and Section 7.03 shall have been satisfied or waived...",
        "reference_section": "ARTICLE Article VIII TERMINATION > Section 8.01 Termination and Abandonment > (b)"
      }
    ],
    "marketing_period_dates": [
      {
        "section": "timeline",
        "field_name": "marketing_period_dates",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "inside_date": [
      {
        "section": "timeline",
        "field_name": "inside_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "closing_date": [
      {
        "section": "timeline",
        "field_name": "closing_date",
        "answer": "three business days after the date on which all conditions set forth in Article VII shall have been satisfied or waived",
        "summary": "The closing date for the merger is defined as three business days after all conditions in Article VII are satisfied or waived.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the closing will occur three business days after conditions are met.",
        "clause_text": "The closing of the Merger (the \"Closing\") shall take place (a) remotely by electronic exchange of executed documents, commencing at 10:00 a.m., New York City time, on the date that is three (3) business days after the date on which all conditions set forth in Article VII shall have been satisfied or waived (other than those conditions that by their nature are to be satisfied by actions to be taken at the Closing, but subject to the satisfaction or waiver thereof at or prior to the Closing).",
        "reference_section": "ARTICLE Article I THE MERGER > Section 1.02 Closing"
      }
    ],
    "conditions_satisfaction_end_date": [
      {
        "section": "timeline",
        "field_name": "conditions_satisfaction_end_date",
        "answer": "February 5, 2025",
        "summary": "The final date by which all closing conditions must be satisfied under the agreement is February 5, 2025, subject to possible extensions.",
        "confidence": 0.9,
        "reason": "The agreement specifies that the Effective Time must occur on or before February 5, 2025, with provisions for automatic extensions if certain conditions are met.",
        "clause_text": "by either the Company or Parent if (i) the Effective Time shall not have occurred on or before February 5, 2025 (as may be extended pursuant to the following proviso, the \"End Date\"); provided that such date shall automatically be extended by three (3) months on four (4) occasions...",
        "reference_section": "ARTICLE Article VIII TERMINATION > Section 8.01 Termination and Abandonment"
      }
    ]
  }
}